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This is the grass your feet are planted on. 
 
You paint it orange or you sing it green, 
But you have never found 
A way to make the grass mean what you mean. 
 
A cloud can be whatever you intend: 
Ostrich or leaning tower or staring eye. 
 
But you have never found 
A cloud sufficient to express the sky. 
 
Get out there with your splendid expertise; 
Raymond who cuts the meadow does not less. 
 
Inhuman nature says: 
Inhuman patience is the true success. 
 
Human impatience trips you as you run; 
Stand still and you must lie. 
 
It is the grass that cuts the mower down; 
It is the cloud that swallows up the sky. 
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ABSTRACT 
 
A major question in cell biology is, how are materials, such as organelles, transported 
within a cell? The mis-localization of organelles underlies diseases in the skin, gut, and brain. 
Thus, the delivery of organelles to their proper destination is important for cellular function. 
Molecular motor proteins are one way by which cargoes are transported to their destination 
within the cell. Yet, little is known about how cargo transport is regulated. Specifically, it is 
largely unknown how motors release cargo at the correct destination.  
In this thesis, I explore mechanisms that regulate how a myosin V motor transports 
organelles in the budding yeast, Saccharomyces cerevisiae. These studies focus on the vacuole, 
an organelle similar to mammalian lysosomes, which is transported into the daughter bud by 
myosin V during budding/cell division. Myosin V-based transport requires that cargo-specific 
adaptor proteins physically link the motor to the cargo. Early in the cell cycle, the vacuole-
specific adaptor, Vac17, bridges a myosin V motor, Myo2, to the vacuole. Both the attachment 
and the detachment of the vacuole to/from Myo2 is highly controlled.  
Release of Myo2 from the vacuole is mediated through Vac17. Vac17 is regulated by 
post-translational modifications. Dma1, an E3 ubiquitin ligase, ubiquitylates Vac17, which 
targets it for degradation. Interestingly, the bud cortex is a spatial landmark that signals the 
successful delivery of the vacuole to the bud. Upon arrival at the bud cortex, Vac17 is 
phosphorylated by a p21-activated kinase (PAK), Cla4. Cla4-dependent phosphorylation is 
 xiii 
required for the ubiquitylation and subsequent degradation of Vac17. These studies reveal a 
critical step in the spatial regulation of myosin V–dependent organelle transport.  
In addition to ubiquitylation, a second pathway is required to release the vacuole from 
Myo2. A vacuole-localized Casein Kinase I, Yck3, along with the homotypic fusion and protein-
sorting (HOPS) subunit, Vps41, regulate the phosphorylation of Vac17 in its Myo2 binding 
region. Yck3 and Vps41-dependent phosphorylation results in the dissociation of ubiquitylated 
Vac17 from the motor-adaptor complex. Moreover, ubiquitylation of Vac17 can occur 
independent of Yck3 and Vps41. Conversely, Yck3 and Vps41 -dependent phosphorylation can 
occur without ubiquitylation. However, both signals must be present for the vacuole to be 
released from Myo2 and for Vac17 to be degraded. Thus, the termination of cargo transport is 
tightly regulated and likely critical to cellular health and function. 
Overall, these studies reveal some of the mechanisms required to release cargo from 
their motors at the right place and time. Many of the players are conserved in mammalian cells. 
Thus, it is tempting to speculate that these mechanisms are conserved for other yeast myosin V 
cargoes, as well as conserved in mammalian cells. Further work based on these findings has the 
promise to provide greater insight into motor-based cargo transport, how protein complexes 
are dissociated, and how proteins are regulated and degraded in coordination with cellular 
events. 
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CHAPTER I 
INTRODUCTION 
 
Intracellular Cargo Transport 
 The correct positioning of contents within a cell is crucial to cellular function. The 
movement and delivery of cellular materials, such as organelles, is essential for response to 
stimuli and for the establishment and maintenance of homeostasis and cellular identity. 
Organelles are dynamic and change morphology and location depending on cellular 
requirements, such as during cell division (Jongsma et al., 2015). For example, lysosomes 
may change localization in response to stimuli, such as starvation, presumably to help 
degrade contents that are in other parts of the cell (Oyarzun et al., 2019). Additionally, their 
position within a cell is linked to their luminal pH, and thus function (Johnson et al., 2016). 
Cargo transport is mediated in part by molecular motors. Accurate transport by molecular 
motors requires several regulated steps: 1) correct orientation of cytoskeletal tracks, 2) 
regulation of motor movement along the cytoskeleton, and 3) loading and unloading of 
cargoes on the motor. In many eukaryotic cells, including mammalian cells, long range 
transport occurs via kinesin and dynein on microtubules. At the cell periphery, some 
cargoes are then transferred from kinesin to myosin V motors for short range transport or 
tethering on actin networks (Hancock, 2014). In the budding yeast Saccharomyces 
cerevisiae, myosin V moves several cargoes from the mother to the bud during budding, a 
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version of asymmetric cell division (Weisman, 2006). While myosin V moves towards the 
positive end of actin filaments, myosin VI may transport and tether cargo at the negative 
end of actin (Lister et al., 2004). Here, we focus on myosin V-mediated organelle transport.   
 
Regulation of Myosin V Mediated Transport 
Regulation of the motor domain and movement along actin 
 There are three myosin V isoforms in mammalian cells: myosin Va, Vb, and Vc (Hammer 
and Wagner, 2013). Budding yeast express two myosin V motors: Myo2 and Myo4 (Lu et al., 
2014). The myosin V heavy chain consists of the motor domain, neck domain, and globular tail 
domain (Figure 1.1). Regulation of myosin V occurs in each of these regions, such that 
regulation of the motor and neck domains are largely responsible for movement along the actin 
cytoskeleton, while the tail domain mediates cargo loading and unloading (Heissler and Sellers, 
2016; Lu et al., 2014).  
 The motor domain is required for movement along actin and is the site of ATP hydrolysis 
and actin binding (Heissler and Sellers, 2016; Larson, 1996; Lu et al., 2014). ATP hydrolysis 
regulates the power stroke, a hand over hand movement of the motor domains that allows 
progress along actin (Trybus, 2008). Upon binding to actin, the motor domain can move 
processively on actin-tropomyosin (Hodges et al., 2012; Pruyne et al., 1998). Tropomyosin may 
increase myosin V’s processivity, run length, and/or frequency of actin binding (Heissler and 
Sellers, 2016).   
Motor movement is also regulated by the neck domain of myosin V. The neck domain 
contains IQ motifs that in yeast bind to Mlc1, myosin light chain, for stability (Stevens and 
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Davis, 1998) as well as to calmodulin (Brockerhoff et al., 1994). Calmodulin recruits 
calcium, which leads to conformational changes in myosin V and activates myosin V 
movement (Trybus et al., 2007; Wang et al., 2004). Calcium may regulate activity by also 
relieving the auto-inhibited conformation of mammalian myosin Va in vitro (Wang et al., 
2004). 
 Auto-inhibition is when a motor is folded in an inactive state, with the motor domain 
bound to the tail domain, unless bound to cargo and/or the cytoskeleton (Li et al., 2005; 
Sckolnick et al., 2013). The microtubule based motors, kinesin (Hammond et al., 2010; Kelliher 
et al., 2018; Siddiqui et al., 2019; Verhey and Hammond, 2009) and dynein (Qiu et al., 2019; 
Torisawa et al., 2014), exhibit regulation by auto-inhibition and this inhibition is released upon 
binding to adaptor proteins and cargo. In vitro myosin-Va also shows extended and auto-
inhibited conformations (Heissler and Sellers, 2016), where the auto-inhibited structure has the 
motor domains docked to the tail domains (Krementsov et al., 2004; Li et al., 2004; Liu et al., 
2006; Sato et al., 2007a; Thirumurugan et al., 2006; Wang et al., 2004). One study in yeast 
predicted the docking sites and found that genetic mutants may suggest that auto-inhibition 
has a role in the cellular context (Donovan and Bretscher, 2015). Thus, mechanisms that 
regulate auto-inhibition may apply to both actin and microtubule based motors. 
 
Globular tail domain and cargo-specific adaptor proteins 
 Myosin V motors transport cargoes to their correct intracellular locations (Lu et al., 
2014). The globular tail domain of myosin V must bind to a variety of cargoes under different 
conditions. Myosin-V utilizes cargo-specific adaptor proteins, which allows one tail domain to 
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bind to a variety of cargoes (Cross and Dodding, 2019). A similar strategy also occurs in kinesin 
and dynein. Adaptor binding regions in both the yeast myosin V, Myo2 (Eves et al., 2012; Tang 
et al., 2019), and the mammalian myosin-Va globular tail domain overlap with other adaptor 
binding regions (Wei et al., 2013), which likely causes competition between adaptors and their 
cargoes. Thus, it is likely that there are mechanisms in place to regulate which cargoes are 
bound at a given time or location. Although adaptor proteins themselves are not conserved, 
adaptor proteins are utilized by myosin V motors from yeast to humans and share some 
common structural and regulatory elements (Figure 1.2).  
 Transport initiates when myosin V binds to an adaptor protein and is thus physically 
linked to the cargo (Knoblach and Rachubinski, 2016; Weisman, 2006; Westermann, 2014). 
Binding to the adaptor induces conformational changes in myosin V, as observed in mammalian 
cells (Pylypenko et al., 2013) and yeast (Tang et al., 2019), and may activate the motor 
(Donovan and Bretscher, 2012). Studies of myosin Va suggest that regulation of adaptors can 
influence track selection and actin binding (Oberhofer et al., 2017). The binding of the motor to 
the adaptor may also be facilitated by additional mechanisms. For example, Cdk1 
phosphorylates the yeast vacuole adaptor to regulate its binding to myosin V, and putative 
Cdk1 sites are present in other cargo specific adaptor proteins (Peng and Weisman, 2008). Rab 
GTPases also mediate myosin V binding to cargo. For example, Rab11a binds myosin Va and Vb 
to stimulate membrane tethering (Inoshita and Mima, 2017). Rabs may be part of the motor-
adaptor complex, such as Rab27a, which interacts with the adaptor melanophilin and myosin V 
to mediate melanosome transport (Barral and Seabra, 2004). In yeast, the Rab GTPases Sec4 
and Ypt11 are required for secretory vesicle transport (Jin et al., 2011), and Ypt11 also regulates 
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transport of other organelles (Arai et al., 2008; Chernyakov et al., 2013; Eves et al., 2012; Jin et 
al., 2009; Lewandowska et al., 2013). Regulation through Rab GTPases may provide additional 
specificity. For example, Rab3A binds to myosin Va and Vc, but not Vb (Dolce et al., 2020), 
suggesting that mechanisms regulate specific activity for certain isoforms of myosin V. Rab 
GTPases may also directly regulate motor-adaptor interactions or otherwise facilitate cargo 
movement. For example, interaction with Rab11 and Rab8 may stimulate actin nucleation by 
recruiting Spir (Welz and Kerkhoff, 2019), which is in contrast to the other Rab GTPases 
described that are related to the cargo-specific adaptor proteins.   
 Upon arrival at their correct locations, organelles detach from myosin V, thereby 
terminating transport (Fusheng Tang, 2003). In Xenopus, CK2 phosphorylates the myosin 
tail domain during mitosis (Karcher et al., 2001), to release cargo and reduce the transport 
of cargo, such as melanosomes (Rogers et al., 1999). During budding in yeast, cargo is 
released from myosin V late in the cell cycle (Fusheng Tang, 2003), which provides further 
support to the hypothesis that cargo transport is closely linked with the cell cycle. The 
degradation of adaptor proteins is also highly regulated and may serve to ensure proper 
cargo release from the motor. Melanophilin, the mammalian melanosome adaptor (Park et 
al., 2019b), and Vac17 (Yau et al., 2014; Yau et al., 2017), the yeast vacuole adaptor, are 
ubiquitylated and degraded by the proteasome. It is likely that additional unknown 
mechanisms are required to properly position cargoes within cells.  
 
Myosin and kinesin 
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It is largely unknown how teams of diverse motors are coordinated in a cellular context, 
whether collaboratively or in opposition. When myosin V is recruited to kinesin-propelled 
cargo, it reduces their motility near the cell periphery and enhances their localization at the 
cortex (Kapitein et al., 2013), suggesting that there are mechanisms at the cortex that promote 
actin-based transport over microtubule-based transport. Such regulation may be due to the 
cytoskeleton that is available, and myosin V and kinesin may compete with each other for cargo 
depending on the availability of microtubules (Lu et al., 2020). In some cases, this type of 
competition may promote function, as one study suggests that myosin V and kinesin enhance 
each other processivity by acting as tethers (Ali et al., 2008). In yeast, a catalytically inactive 
kinesin-like protein Smy1 enhances the interaction between Myo2 and the Rab Sec4, which 
links Myo2 to secretory vesicles (Lwin et al., 2016). Smy1 may also regulate formins and thus 
influence actin cables (Chesarone-Cataldo et al., 2011; Eskin et al., 2016). Overall, there are 
many open questions as to how myosin and kinesin motors may cooperate or compete 
depending on the cellular context.  
 
Myosin V Based Organelle Transport in Yeast 
 During budding, the cell division that occurs in Saccharomyces cerevisiae, Myo4 and 
Myo2 transport cargoes into the bud to divide cellular components between mother and 
daughter cells (Bretscher, 2003; Knoblach and Rachubinski, 2015; Weisman, 2006). Myo4 
transports messenger ribonucleoprotein (mRNP) (Singer-Kruger and Jansen, 2014), ASH1 mRNA 
(Dunn et al., 2007) via She2 (Long et al., 2000), and the cortical ER via She3 (Estrada et al., 2003) 
into the bud during budding. On the other hand, Myo2 transports the vacuole (Kent L. Hill, 
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1996; Natalie L. Catlett, 1998), mitochondria (Simon et al., 1995), peroxisomes (Hoepfner et al., 
2001), secretory vesicles (Pruyne et al., 1998), lipid droplets (Knoblach and Rachubinski, 2014), 
and late Golgi (Arai et al., 2008) into the bud. Myo2 also has a role in microtubule spindle 
positioning, which helps position the nucleus for closed mitosis (Hwang et al., 2003; Lee et al., 
2000; Liakopoulos et al., 2003; Miller et al., 2000; Yin et al., 2000). Myo2 likely also binds to 
RNA-containing complexes (Chang et al., 2008). During mating, Myo2 transports Fus2 to the 
bud tip to break down the cell wall (Sheltzer and Rose, 2009). Thus, Myo2 has diverse cargoes 
and must coordinate the transport of these cargoes at the right time and to the right 
destination.  
Organelle transport requires organelle-specific events, such as regulation of the 
cargo-specific adaptor proteins, to allow fine-tuned coordination of movement. 
Transport also requires more broad events that control organelle transport in general. 
For example, the kinase Ptc1 may stabilize the cargo adaptors for mitochondria, 
vacuole, and peroxisome, and thus promote their transport (Jin et al., 2009; Roeder et 
al., 1998). Additionally, the Rab Ypt11 has roles in moving mitochondria (Chernyakov et 
al., 2013; Itoh et al., 2002), ER (Buvelot Frei et al., 2006), and late Golgi (Arai et al., 
2008). This suggests conservation of mechanisms across organelles or cooperative 
mechanisms that links the movement of several organelles. 
Even for organelles that can be produced de novo, such as the vacuole, 
inheritance of mature organelles likely provides a competitive advantage (Jin and 
Weisman, 2015). Another advantage is that asymmetric inheritance allows the cell to 
rejuvenate the bud and leave potentially toxic materials in the mother, and thus extend 
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lifespan (Hill et al., 2014; Nystrom and Liu, 2014). It could also act as a protective measure, such 
as in the case where acute stress inhibits ER inheritance, and thus daughter cells are not viable 
(Babour et al., 2010). Below we discuss four examples of myosin V cargoes in yeast: two 
essential cargoes, secretory vesicles and mitochondria, and two other cargoes that have also 
been extensively studied, peroxisomes and vacuoles.  
 
Secretory vesicles 
 Secretory vesicles are an essential Myo2 cargo and are required for bud growth and 
sealing the mother-bud interface during cytokinesis (Johnston et al., 1991; Schott et al., 1999). 
An early observation found that a myosin V mutant, myo2-66 (Lillie and Brown, 1994), was 
impaired in moving secretory vesicles (Johnston et al., 1991). Myo2 motor function is likely 
activated upon binding to secretory vesicles (Donovan and Bretscher, 2012). GTP-bound 
Ypt31/32, members of the Rab11 GTPase family, bind to Myo2 to promote secretory vesicle 
growth and transport (Lipatova et al., 2008). After transport into the bud, secretory vesicles 
tether at the bud tip before membrane fusion (Donovan and Bretscher, 2015). Tethering and 
fusion of secretory vesicles requires that Myo2 interacts with the Rab Sec4 and the exocyst 
subunit Sec15 (Jin et al., 2011). The kinesin-like protein Smy1 may promote Myo2 interaction 
with Sec4 (Lwin et al., 2016). At a late step, release of secretory vesicles is triggered by GTP 
hydrolysis during tethering (Donovan and Bretscher, 2012). 
 
Mitochondria 
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 Since mitochondria are essential (McConnell et al., 1990) and cannot be made de novo, 
multiple pathways, including Myo2-independent pathways, ensure their inheritance. Yeast are 
able to scale how many mitochondria are inherited to the size of the bud (Rafelski et al., 2012). 
Ideally, about half of mitochondria are inherited by the bud (Boldogh et al., 2003; Simon et al., 
1997). The region of Myo2 that binds to the mitochondria-specific adaptor, Mmr1, has overlap 
with binding regions to other adaptor proteins (Eves et al., 2012), suggesting that additional 
mechanisms, such as competition, coordinate cargo transport. The Rab GTPase Ypt11 (Arai et 
al., 2008; Chernyakov et al., 2013; Itoh et al., 2002; Lewandowska et al., 2013) and Mmr1 
(Chernyakov et al., 2013; Eves et al., 2012; Itoh et al., 2004) facilitate Myo2 dependent 
transport and anchoring in the bud, as well as link mitochondria to cortical ER (Itoh et al., 2002; 
Swayne et al., 2011). The mitochondrial rho (Miro) GTPase Gem1 also facilitates Myo2 
dependent movement, but Ypt11, Mmr1, and Gem1 may function in independent pathways 
(Frederick et al., 2008). Note that Miro and its function in mitochondrial distribution is 
conserved in higher eukaryotes (Fransson et al., 2003; Fransson et al., 2006).  
In the bud and the mother, mitochondria are anchored to the cell periphery. 
MECA is a complex of Num1 and Mdm36 that tethers mitochondria and ER to the 
mother cell cortex (Lackner et al., 2013). Mfb1 also aids in tethering mother cell 
mitochondria, independent of Num1 (Pernice et al., 2016). In addition to serving as the 
Myo2 adaptor, Mmr1 may tether mitochondria to the bud cortex (Swayne et al., 2011), 
though it is difficult to distinguish polarized movement towards the bud tip from 
tethering at the bud tip, and it is likely that Mmr1 is acting as an adaptor as opposed to 
a tether (Eves et al., 2012). Mmr1 and Num1 likely oppose each other, as deletion of 
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Mmr1 results in more mitochondria in the mother (Eves et al., 2012; Itoh et al., 2004; Swayne 
et al., 2011), while deletion of Num1 results in more mitochondria in the bud (Klecker et al., 
2013; Lackner et al., 2013).  
In addition to myosin V mediated movement, the cytoskeleton itself may have roles in 
mitochondria movement (Klecker and Westermann, 2020). Puf3 facilitates binding of 
mitochondria, via the mitochore, to Arp2/3 (Garcia-Rodriguez et al., 2007). Subsequent actin 
polymerization may propel mitochondria into the bud (Boldogh et al., 2001). Mdm10, Mdm12, 
and Mmm1, members of the ERMES complex (Kornmann et al., 2009), potentially recruit 
Apr2/3 (Boldogh et al., 1998; Boldogh et al., 2003). However, it is unknown if this pathway plays 
a significant role in mitochondrial inheritance. Note that in mammalian cells, actin cycling may 
regulate mitochondrial fission and fusion dynamics (Moore et al., 2016).  
 Mitochondrial transport is also linked to mitochondrial morphology, which is maintained 
through regulated fission and fusion, as well as the health of the mitochondria. Myo2 is 
required for mitochondrial fusion, which in turn affects mitochondrial inheritance and retention 
of protein aggregates in the mother (Bockler et al., 2017). Several groups observed that only 
healthy mitochondria are inherited by the bud (Higuchi et al., 2013; McFaline-Figueroa et al., 
2011; Vevea et al., 2013). Anchoring likely enables these healthy mitochondria to be selectively 
kept in the bud (Knoblach and Rachubinski, 2015). The selection of healthy mitochondria to be 
moved into the bud may be related to actin cables as well, as healthy mitochondria have to 
move in the opposite the direction of retrograde actin cable flow (Higuchi et al., 2013). The 
asymmetrical inheritance of mitochondria likely contributes to rejuvenating the daughter bud 
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(Hughes and Gottschling, 2012; McFaline-Figueroa et al., 2011; Pernice et al., 2016). Yet, the 
mechanisms that select which mitochondria are transported, and to where, are still unclear. 
 
Peroxisomes 
 Peroxisomes are transported by Myo2 via the peroxisome specific adaptors Inp2 
(Fagarasanu et al., 2006) and Pex19 (Otzen et al., 2012). Inp2 is phosphorylated in coordination 
with the cell cycle, with higher levels of phosphorylation at the beginning and end of the cycle, 
suggesting that post-translational modifications may regulate peroxisome transport 
(Fagarasanu et al., 2009; Oeljeklaus et al., 2016). Additionally, the Inp2 binding region on Myo2 
partially overlaps with the secretory vesicle binding region (Fagarasanu et al., 2009; Tang et al., 
2019), suggesting that there may be additional regulatory pathways that determine which 
cargoes are moved at a given time. Note that peroxisome transport occurs before 
mitochondrial transport in budding yeast (Knoblach et al., 2013).  
After being transported into the bud, Inp2 is degraded and peroxisomes are 
released from Myo2 (Fagarasanu et al., 2009). Yeast may ‘count’ how many 
peroxisomes are in the mother and the bud, and control Myo2-mediated inheritance 
accordingly, such as by increasing the amount of Inp2 (Fagarasanu et al., 2009; Knoblach 
and Rachubinski, 2015). Notably, Inp2 also has roles in peroxisome division (Knoblach 
and Rachubinski, 2015), suggesting that division and transport may be coordinated to 
achieve the right amount of peroxisomes in the bud. This process may also be regulated 
by Vps1 (Hoepfner et al., 2001). 
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In contrast to Inp2, which is only found in the bud (Fagarasanu et al., 2006), Inp1 acts as 
a peroxisome tether at the cell periphery (Fagarasanu et al., 2005) in the mother cell (Knoblach 
et al., 2013), and also interacts with the ER-localized Pex3 (Knoblach et al., 2013; Munck et al., 
2009). In the filamentous fungus, Aspergillus nidulans, peroxisomes hitchhike on early 
endosomes as a mode of transportation (Salogiannis et al., 2016). In A nidulans, long range 
organelle transport occurs along microtubules, so it is unknown if these hitchhiking 
mechanisms are conserved for actin-based transport or in mammalian cells.  
 
Vacuole 
 Although vacuoles can be made de novo in the bud, the presence of a vacuole that is of 
proper size is required for cell cycle progression and for the initiation of bud emergence (Jin and 
Weisman, 2015). At the beginning of the cell cycle in S. cerevisiae, the myosin V motor, Myo2, 
binds the vacuole adaptor, Vac17, and transports a portion of the mother vacuole into the bud 
(Fusheng Tang, 2003; Ishikawa et al., 2003) (Figure 1.3A). The attachment between Myo2 and 
Vac17 is regulated by the cyclin dependent kinase, Cdk1, which phosphorylates Vac17 (Peng 
and Weisman, 2008). The peroxisome adaptor, Inp2, and the mitochondria adaptor, Mmr1, also 
contain potential Cdk1 sites (Peng and Weisman, 2008). Vac17 also binds to Vac8, which is 
associated with the vacuole via myristoylation and palmitoylation (Tang et al., 2006; Yong-Xu 
Wang, 1998).  The formation of the Myo2-Vac17-Vac8 complex physically bridges Myo2 to the 
vacuole (Fusheng Tang, 2003; Ishikawa et al., 2003). Importantly, translation, phosphorylation, 
and degradation of Vac17 is coordinated with the cell cycle and Vac17 levels peak at the same 
time that vacuole transport occurs (Fusheng Tang, 2003; Peng and Weisman, 2008) 
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Vac8 has other cellular roles, including being part of the nuclear-vacuole 
junction, an organelle contact site between the ER and vacuole, and  the site of 
piecemeal micro-autophagy of the nucleus (Kvam and Goldfarb, 2007). A recent 
structure suggests that Vac8 may have different quaternary structures depending on its 
binding partners, and that these distinct orientations correlate with function (Park et al., 
2019a). The structure of Vac8 bound to Vac17 is currently unknown. Note that the 
structures of Myo2 bound to Smy1, Mmr2, and Inp2 is known (Tang et al., 2019), but the 
structure of Myo2 bound to Vac17 remains unsolved. One caveat of the Myo2 study is 
that the adaptors were tethered to the motor, raising the possibility that the structures 
are artifacts of the tether. Aside from vacuole transport, Vac17 may have a role in the 
asymmetric inheritance of protein aggregates, as related to aging (Hill et al., 2016). It is 
unclear if Vac17 has a significant role in the cell aside from vacuole transport.   
After it is delivered into the bud, the vacuole is released from Myo2, and Vac17 
is degraded (Fusheng Tang, 2003). The E3 ubiquitin ligase, Dma1, ubiquitylates Vac17 
and Vac17 is degraded by the proteasome (Yau et al., 2014). Degradation of Vac17 
depends on its PEST sequence (Fusheng Tang, 2003). Note that Inp2 also contains PEST 
sequences and is degraded in the bud (Fagarasanu et al., 2006). Additionally, the astral 
microtubule adaptor Kar9, is ubiquitylated and degraded (Kammerer et al., 2010). Late 
in the cell cycle, Myo2 transports secretory vesicles, but not the vacuole, to the mother-
bud neck (Govindan et al., 1995; Pruyne et al., 1998; Schott et al., 1999). In mutants 
defective in the degradation of Vac17, the vacuole remains attached to Myo2 and is 
inappropriately transported to the mother-bud neck late in the cell cycle (Fusheng Tang, 
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2003) (Figure 1.3B). Dma1 is also essential for the release of peroxisomes from Myo2, 
suggesting a conserved role for Dma1 in terminating Myo2-mediated cargo transport 
(Yau et al., 2014).  
 In yeast, the p21-activated kinases (PAKs) Cla4 and Ste20, localize to the bud cortex and 
regulate several cell cycle related processes including actin cytoskeleton polarization, septin 
ring assembly, and cytokinesis (Boyce and Andrianopoulos, 2011; Cvrckova et al., 1995; Kumar 
et al., 2009; Peter et al., 1996). Moreover, it was proposed that PAKs indirectly regulated 
vacuole inheritance via Lte1, a Cla4-activated guanine nucleotide exchange factor 
(Bartholomew and Hardy, 2009).  Thus, it is likely that additional mechanisms regulate the 
transport of the vacuole. 
 It is largely unknown why such complicated mechanisms are required to detach the 
vacuole from Myo2, especially since defects in this process are not lethal to the cell. It is 
possible that the degradation of Vac17 ensures that the Myo2-Vac17-Vac8 complex does not 
reform, accidentally sequestering Myo2 and Vac8 from their other functions. It is also possible 
that degradation of Vac17 allows the new synthesis of Vac17 during the next cell cycle to drive 
vacuole transport. Further studies of vacuole transport may reveal some of the physiological 
reasons for these mechanisms. 
 
Myosin V in Mammalian Cells and Disease 
 Myosin V motors are conserved across eukaryotes, and it is tempting to speculate that 
the mechanisms that regulate myosin V-based transport are also conserved (Hammer and 
Sellers, 2012; Trybus, 2008). Mammals express three myosin V motors: myosin-Va (MYO5A), -
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Vb (MYO5B), and –Vc (MYO5C) (Heissler and Sellers, 2016; van der Velde et al., 2013). Myosin 
Va is found predominately in the brain, while Myosin Vb and Vc are in non-neuronal tissues, 
such as epithelial tissues (Rodriguez and Cheney, 2002). Mutations in myosin V motors have 
been implicated in a variety of diseases (Çağdaş et al., 2012; Chen et al., 2013; Dong et al., 
2012; Elodie Pastural, 1997; Hammer and Wagner, 2013; Muller et al., 2008; Takagishi and 
Murata, 2006; Thoeni et al., 2014; van der Velde et al., 2013). Defects in the attachment of 
cargoes to motors, as well as the inability to detach cargoes from motors, may cause these 
diseases since both cases would prevent the proper localization of cargoes. Furthermore, if a 
motor cannot detach from one cargo, it is likely that it would not be able to attach to and 
transport other cargoes. 
 Defects in myosin V based transport become most prominent in polarized tissue types, 
such as gut epithelial cells. In gut cells, the Rab11/Slp4/Myo5b/Munc18 complex carries vesicles 
to the apical surface, where they bind to STX3 for membrane fusion (Vogel et al., 2015). 
Mutations in MYO5B cause a loss of cell polarity and identity, resulting in microvillus inclusion 
disease (MVID), a rare disease where the gut is unable to absorb nutrients (Muller et al., 2008; 
Thoeni et al., 2014; van der Velde et al., 2013). Both constitutive (Carton-Garcia et al., 2015) 
and conditional (Schneeberger et al., 2015) knockout of MYO5B serve as mouse models for 
MVID. Loss of function mutants in Rab8 (Sato et al., 2007b) and Rab11 (Sobajima et al., 2014) 
also mimic MVID. Downregulation of MYO5B is also associated with the progression of gastric 
cancer (Dong et al., 2012), supporting the idea that myosin V mediated transport maintains gut 
cell identity and function. 
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 Myosin V also has a prominent role in neurons. Myosin Va transports ER into dendritic 
spines of purkinje neurons (Wagner et al., 2011). Myosin Vb moves recycling endosomes and 
AMPA receptors (Wang et al., 2008). Myosin Va acts as a tether in synapses to promote 
neurotransmitter release (Maschi et al., 2018). Myosin Va is recruited to secretory granules that 
contain Rab27a and granuphilin-a/b or rabphillin-3A (Brozzi et al., 2012). Griscelli syndrome, a 
disease that is characterized by neurologic and pigmentation deficiencies, can be caused by 
mutations in myosin Va (Çağdaş et al., 2012; Elodie Pastural, 1997; Takagishi and Murata, 2006; 
Van Gele et al., 2009).  
 Pigmentation defects can be traced to a role for myosin Va in melanocyte function. 
Myosin Va positions melanosomes for proper pigmentation (Wu et al., 1998). Melanophilin, 
Rab27a, and myosin Va form a complex to transport melanosomes to the cell periphery, where 
they are positioned at the cell cortex for proper delivery to keratinocytes (Fukuda et al., 2002; 
Strom et al., 2002). Melanophilin/Slac2-a serves as the melanosome specific cargo adaptor 
(Provance et al., 2002; Wu et al., 2002b) and enhances myosin V processivity (Sckolnick et al., 
2013). Rab27a likely interacts with myosin Va indirectly, but is still required for melanosome 
transport (Wu et al., 2002a). Rab36 may promote RILPL2 interaction with myosin V, which then 
allows Melanophilin to bind the globular tail domain (Cao et al., 2019). Note that similar to the 
yeast cargo adaptors Vac17 and Inp2, Melanophilin also contains PEST sequences (Fukuda and 
Itoh, 2004). Deletion of one of the PEST sequences of Melanophilin results in stabilization of 
Melanophilin and mis-localization of melanosomes (Fukuda and Itoh, 2004). Thus, studies of 
how the Vac17-PEST sequence regulates yeast vacuole transport may provide insight into how 
mammalian cargo adaptors are regulated.  
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Unanswered Questions   
Although recent studies have revealed novel mechanisms in cargo transport, 
many questions remain unanswered. Even in the case of the yeast vacuole, where 
several studies have uncovered key mechanisms, there is still more to be learned, and 
these studies may apply to other cargoes (Figure 1.4). It is still unknown how the site of 
Myo2 attachment to the vacuole is chosen. Although Vac8 is found along the vacuole 
membrane, only one punctum of Vac17 and Myo2 localize to the vacuole. It is unclear 
how the leading edge of the vacuole is chosen. It is possible that this signaling depends 
on cell polarization or bud growth factors, organelle contact sites, signaling 
phosphoinositide lipids, or trafficking of endosomes. Alternatively, or in addition, the 
directional movement of Myo2, may bring together a domain of the vacuole that forms 
the leading edge. In support of this hypothesis, in Myo2 mutants that cannot bind 
Vac17, Vac17 and Vac8 are distributed throughout the vacuole membrane. During 
vacuole transport, it is unclear if anything anchors the mother vacuole. Anchor proteins 
have been identified for other organelles in yeast, but none have been shown to anchor 
the vacuole.  
Additionally, there are likely other factors that contribute to the formation of the 
Myo2/Vac17/Vac8 complex. While previous studies identified Cdk1 as regulating the 
interaction between Vac17 and Myo2, it is unclear what facilitates Vac17 and Vac8 
binding. It is also unknown if Vac17 binds Myo2 or Vac8 first. It is also possible that 
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additional binding partners or membrane structures, such as structural and signaling lipids, 
could stabilize the complex at the leading edge of the vacuole. 
After proper delivery of the vacuole, the membrane structure between mother and 
daughter vacuole, known as the segregation structure, resolves. The segregation structure may 
either be a long tubule, or several small vacuoles strung together (Weisman, 2003). It is still 
unknown what regulates the resolution of the segregation structure, both in timing its 
resolution, as well as physically disconnecting the mother and daughter vacuoles. It is possible 
that there is a mechanism for fission, or release between two tethered vesicles.  
Furthermore, there are still open questions as to how Myo2 releases the vacuole. 
Although previous work showed that Cla4 phosphorylates Vac17, it is unclear how this 
phosphorylation event regulates the ubiquitylation of Vac17. This phosphorylation event could 
be changing Vac17 conformation to reveal a ubiquitylation site, or it may be recruiting a binding 
partner that activates Dma1 E3 ligase activity. After the ubiquitylation of Vac17, it is unknown 
how the Myo2/Vac17/Vac8 complex dissociates. Vac17 could be immediately degraded or 
could be detached from either Myo2 or Vac8 before being delivered to the proteasome. It is 
also unclear how Yck3 and Vps41 are acting to regulate this step. Further studies into these 
mechanisms will reveal how cargo transport is regulated in cells. 
It is tempting to speculate that the mechanisms we discover in yeast will be applicable 
to mammalian cells and disease. Very little is known about how cargoes are released from their 
motors, in any organism. Yet, it is highly likely that the release of cargoes is important for 
animal physiology. For example, phosphorylation of the kinesin motor KIF17 may be important 
for the loading and unloading of NMDA receptors, and thus synaptic plasticity (Yin et al., 2012). 
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Additionally, Melanophilin is ubiquitylated and this ubiquitylation is enhanced in the 
absence of Rab27a (Park et al., 2019b), suggesting that adaptors are more stable in their 
motor-adaptor complex. Thus, general themes of how cargoes released from the motor 
and how motor-adaptor complexes are regulated are likely conserved. 
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Figure 1.1. Myosin V is composed of several unique domains.  
The myosin V monomer dimerizes via the coiled-coil domain. The motor domain is the site of 
ATP hydrolysis. The IQ motifs bind calmodulin. The globular tail domain binds cargo-specific 
adaptors.  
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Figure 1.2. The use of adaptor proteins is conserved across organelles and organisms.  
Myosin V attaches to cargo through cargo-specific adaptor proteins. For example, in yeast, 
Myo2 can attach to the vacuole via Vac17 and Vac8. If Myo2 is instead bound to Inp2, it will 
transport peroxisomes. While adaptor proteins are not conserved, mammalian myosin V also 
attaches to cargoes via adaptors. For example, myosin Va attaches to melanosomes via 
Melanophilin and Rab27a.  
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A) 
 
B) 
 
Figure 1.3. Vacuole transport is coordinated during yeast budding.  
A) Early in the cell cycle, Vac17 binds to Myo2 and Vac8, allowing Myo2 to bring a portion of the 
vacuole into the bud. Later in the cell cycle, Vac17 is degraded and the vacuole is released from 
Myo2. When the actin cytoskeleton reorganizes to the mother-bud neck, Myo2 transports 
different cargo, such as secretory vesicles (SV). 
B) In mutants that are defective in the degradation of Vac17, there are also defects in the 
termination of vacuole transport. The initiation of transport occurs as normal. However, Vac17 
is not degraded and Myo2 does not release the vacuole. Thus, Vac17 and the vacuole 
accumulate at the bud tip or mother-bud neck. 
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Figure 1.4. Insights into vacuole transport may reveal mechanisms of motor-based cargo 
transport.  
Many open questions about yeast vacuole transport remain. Uncovering mechanistic details 
about how myosin V moves the vacuole in yeast may reveal key regulatory pathways that are 
also important for human cells, and thus disease.  
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CHAPTER II 
 
SPATIAL REGULATION OF ORGANELLE RELEASE FROM MYOSIN V TRANSPORT BY P21-
ACTIVATED KINASES 
 
 
The work in this chapter was previously published as follows: Yau*, R.G., Wong*, S., and 
Weisman, L.S. (2017) Spatial regulation of organelle release from myosin V transport by p21-
activated kinases. J Cell Biol. Jun 5;216(6):1557-1566. doi: 10.1083/jcb.201607020. Epub 2017 
May 11. * indicates equal contribution.  
 
S. Wong contributed in writing part of the manuscript and revisions, strain generation, and 
performing experiments represented in Figures 2.1, 2.2, 2.4, 2.5, 2.7, 2.8, and 2.9.  
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Introduction 
Myosin V motors transport organelles to their correct intracellular locations. Transport 
initiates when myosin V binds cargo specific adaptors and attaches to organelles (Knoblach and 
Rachubinski, 2016; Weisman, 2006; Westermann, 2014). Upon arrival at their correct locations, 
organelles detach from myosin V, thereby terminating transport. The molecular mechanisms 
that signal the arrival of organelles at their correct locations remain unclear. 
 At the beginning of the cell cycle in S. cerevisiae, the myosin V motor, Myo2, binds the 
vacuole adaptor, Vac17, and transports a portion of the mother vacuole into the bud (Fusheng 
Tang, 2003; Ishikawa et al., 2003). In the bud, the vacuole is released from Myo2 and Vac17 is 
degraded (Fusheng Tang, 2003). Degradation of Vac17 requires phosphorylated Vac17-T240, 
which recruits the E3 ubiquitin ligase, Dma1. Dma1 then ubiquitylates Vac17, targeting Vac17 
for degradation by the proteasome (Yau et al., 2014). Late in the cell cycle, Myo2 transports 
secretory vesicles, but not the vacuole, to the mother-bud neck (Govindan et al., 1995; Pruyne 
et al., 1998; Schott et al., 1999). In mutants defective in the degradation of Vac17, the vacuole 
remains attached to Myo2 and is inappropriately transported to the mother-bud neck late in 
the cell cycle (Fusheng Tang, 2003; Yau et al., 2014). 
In yeast, the p21-activated kinases (PAKs) Cla4 and Ste20, localize to the bud cortex and 
regulate several cell cycle related processes including actin cytoskeleton polarization, septin 
ring assembly, and cytokinesis (Boyce and Andrianopoulos, 2011; Cvrckova et al., 1995; Kumar 
et al., 2009; Peter et al., 1996). Moreover, it was proposed that PAKs indirectly regulated 
vacuole inheritance via Lte1, a Cla4-activated guanine nucleotide exchange factor 
(Bartholomew and Hardy, 2009). 
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Here, we report that PAKs directly phosphorylate Vac17 to signal the arrival of the 
vacuole at its correct location. We show that before the termination of vacuole inheritance, the 
vacuole extends to the bud cortex where Vac17 colocalizes with Cla4. In contrast to the 
previous study, we find that neither degradation of Vac17 nor termination of vacuole transport 
require Lte1. Instead, Cla4 directly phosphorylates Vac17-S222. This phosphorylation event is 
required for Dma1-dependent ubiquitylation and degradation of Vac17, and the release of the 
vacuole from Myo2. Moreover, in a Vac17 mutant that cannot be phosphorylated at S222, the 
vacuole remains attached to the bud cortex, which suggests that this is the intracellular location 
where Cla4 phosphorylates Vac17. Together, these studies suggest that at the bud cortex, Cla4 
initiates a signaling cascade to regulate the ubiquitylation of Vac17 and complete the 
termination of vacuole transport, thereby ensuring that the vacuole is deposited at the correct 
intracellular location.  
 
Results 
PAKs are required for Vac17 degradation and the termination of vacuole transport 
A previous study suggested that Lte1 regulated Vac17 degradation (Bartholomew and 
Hardy, 2009). However, it was unknown whether Lte1 directly regulates the termination of 
vacuole transport. To investigate whether Lte1 acts in this pathway, we tested the lte1Δ mutant 
for the stabilization of Vac17-GFP and the mislocalization of Vac17-GFP and the vacuole to the 
mother-bud neck in large-budded cells. However, these defects were not observed in the 
absence of LTE1 (Figure 2.1A-C). We then measured the impact of PAK function on vacuole 
inheritance. Vac17 levels were not detectably elevated in the cla4∆ or ste20∆ mutants. 
Furthermore, only a partial defect in the termination of vacuole was observed, whereby Vac17-
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GFP and the vacuole colocalized at the bud tip and mother bud neck in some large-budded 
cells. These phenotypes were more prominent in the cla4∆ mutant (Figure 2.1D-F). 
Because PAKs are functionally redundant and synthetically lethal, we performed 
experiments in the ste20Δ cla4ts double mutant (Cvrckova et al., 1995; Holly and Blumer, 1999; 
Martin et al., 1997; Tatebayashi et al., 2006). At 24°C, the levels of Vac17 in the ste20Δ cla4ts 
mutant were similar to wild type levels. In contrast, at 37°C, Vac17 is stabilized and exhibits an 
increase in electrophoretic mobility, which suggests a loss of post-translational modifications 
(Fig 2.2A). In the ste20Δ cla4ts mutant at 24°C, there was partial mislocalization of the vacuole 
with Vac17-GFP, consistent with the earlier result that the ste20Δ mutant has a minor defect in 
the termination of vacuole transport. In large-budded ste20Δ cla4ts cells at 37°C, Vac17-GFP and 
the vacuole accumulated at the mother-bud neck, similar to the dma1∆ dma2∆ mutant (Yau et 
al., 2014). Intriguingly, we also observed Vac17 and the vacuole at a new aberrant location: the 
bud tip. This raises the possibility that the bud cortex is the landmark where Myo2 releases the 
vacuole. In addition, Vac17-GFP and the vacuole mis-localized to the cell cortex at a site 
adjacent to the mother-bud neck (a location on the cortex between the bud tip and mother-
bud neck). This localization had not been previously reported for the vacuole or Myo2 (Fig 2.2B-
C). The mis-localization of the vacuole to this site may be caused by defects in the organization 
of the actin cytoskeleton in the ste20Δ cla4ts mutant (Holly and Blumer, 1999). 
To test if PAK function is required to detach the vacuole from Myo2, we analyzed 
colocalization between Myo2-Venus and the vacuole in large-budded cells. In wild type cells at 
24°C and 37°C the vacuole detached correctly and did not colocalize with Myo2-Venus. In the 
ste20Δ cla4ts mutant at 24°C, there was a modest defect in the termination of vacuole 
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transport. At 37°C in the ste20Δ cla4ts mutant, there is a strong defect in the detachment of the 
vacuole from Myo2-Venus. The vacuole colocalized with Myo2-Venus at the bud tip, mother-
bud neck, and adjacent to the mother-bud neck (Fig 2.2D-E). These observations suggest that 
PAK-dependent signaling regulates Vac17 levels, the release of the vacuole from Myo2 and the 
termination of vacuole transport.  
 
Cla4 phosphorylates Vac17 in vivo and in vitro 
 That PAKs regulate Vac17 levels independently of Lte1 suggests that PAKs directly target 
Vac17. In support of this hypothesis, recombinant GST-Cla4, but not GST alone, binds Vac17-
TAP from cell extracts (Fig 2.3A). Cla4 phosphorylates serines within the consensus motif RxS 
(Mok et al., 2010; Versele and Thorner, 2004; Wu et al., 1996). Interestingly, Vac17-S222 
matches this motif, Vac17-R220LS222, and is required for Vac17 degradation and the termination 
of vacuole transport (Yau et al., 2014). To determine whether Vac17-S222 is a Cla4 
phosphorylation site, we generated a phospho-specific antibody for Vac17-pS222 and tested it 
against Vac17-GFP and vac17-S222A-GFP expressed in vac17Δ or dma1Δdma2Δvac17Δ 
mutants. Deletion of DMA1 and DMA2 stabilizes phosphorylated Vac17, thereby facilitating its 
detection (Yau et al., 2014). The anti-pS222 antibody recognized Vac17-GFP, but not vac17-
S222A-GFP (Fig 2.3B). Furthermore, this antibody does not recognize de-phosphorylated Vac17-
GFP, indicated by an increase in electrophoretic mobility, in λ-phosphatase treated samples (Fig 
2.3C). These results demonstrate the specificity of this antibody for Vac17-pS222 and that 
Vac17-S222 is phosphorylated in vivo.  
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To test whether PAK activity is required for the phosphorylation of Vac17-S222 in vivo, 
we analyzed Vac17-S222 phosphorylation in the ste20Δ cla4ts mutant. Inactivation of PAK 
activity reduced phosphorylation of Vac17-S222. This result suggests that PAK activity is 
required for the phosphorylation of S222 in vivo. Phosphorylation of T240 may have been 
slightly affected by reduced pS222 or by indirect effects of the ste20Δ cla4ts mutant (Fig 2.3D-
E).  
 Since Vac17-S222 matches the Cla4 consensus site, we tested whether Cla4 directly 
phosphorylates Vac17. We performed in vitro kinase assays using recombinant GST-Cla4 and a 
6xHIS-Vac17(96-355) peptide. Phosphorylation was detected via immunoblotting with the anti-
pS222 antibody. GST-Cla4, but not kinase-dead GST-cla4-K594A, phosphorylated 6xHIS-
Vac17(96-355) in an ATP dependent manner. Additionally, the antibody did not recognize 
products of this reaction if the 6xHIS-vac17-S222A(96-355) peptide was used (Fig 2.3F). 
Together, these results demonstrate that Cla4 directly phosphorylates Vac17-S222.  
 
Phosphorylation of Vac17-S222 is required for the termination of vacuole transport 
To gain insight into the role of Vac17-pS222, we tested the termination of vacuole 
transport in cells expressing the non-phosphorylatable vac17-S222A-GFP mutant. In large 
budded cells, vac17-S222A-GFP mis-localized with the vacuole at the mother-bud neck similar 
to vac17-T240A-GFP. Upon closer analysis, both vac17 mutants also accumulated with the 
vacuole at the bud tip in large budded cells before re-localizing to the mother-bud neck, as seen 
in the ste20Δ cla4ts mutant. In contrast, the vacuole was properly localized in the bud and no 
GFP signal was detected in cells expressing Vac17-GFP (Fig 2.4A-B). These results demonstrate 
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that phosphorylation of Vac17-S222 is required to terminate vacuole transport and supports 
the hypothesis that termination of transport initiates at the bud tip. In addition, the localization 
of Myo2 was not perturbed by the mis-localization of the vacuole (Fig 2.4C-E) or Vac17 (Fig 
2.4F-H) in the vac17-S222A-GFP and vac17-T240A-GFP mutants. This suggests that the 
trajectory of Myo2 is not dictated by its bound cargoes. 
 
Vac17-pS222 is required for the ubiquitylation of Vac17 
The termination of vacuole transport occurs in regulated steps: (1) Vac17-T240 is 
phosphorylated, (2) Dma1 is recruited to the vacuole, (3) Dma1 ubiquitylates Vac17, and (4) 
Vac17 is degraded to release the vacuole from Myo2 (Yau et al., 2014). Since Vac17-S222 is 
required for the termination of vacuole transport, we tested whether Vac17-S222 functions at 
any of the above known steps. Immunoblotting with the anti-pT240 antibody demonstrated 
that Vac17-GFP and vac17-S222A-GFP, but not vac17-T240A-GFP were phosphorylated at T240. 
Conversely, Vac17-GFP and vac17-T240A-GFP, but not vac17-S222A-GFP, were phosphorylated 
at S222 (Fig 2.5A-B). These results demonstrate that phosphorylation of Vac17-S222 and Vac17-
T240 occur independently of each other and are consistent with the trend of reduced Vac17-
S222 phosphorylation during PAK inactivation (Fig 2.3D-E).  
To determine whether Vac17-S222 is required for the recruitment of Dma1 we tested 
the localization of Dma1-GFP during vacuole transport. We observed Dma1-3xGFP at the bud 
vacuole in the majority of small budded cells expressing vac17-S222A, similar to wild type. This 
contrasts with the vac17-T240A mutant, which is defective in Dma1 recruitment (Fig 2.5C-D). 
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That Dma1 is recruited to the vacuole in cells expressing vac17-S222A is consistent with the 
observation that vac17-S222A does not impair phosphorylation of Vac17-T240.   
Since recruitment of Dma1 to the vacuole is unperturbed in the vac17-S222A mutant, 
we predicted that vac17-S222A would be ubiquitylated similar to wild type. To test this 
hypothesis, VAC17-GFP or vac17-S222A-GFP were overexpressed in vac17Δ cells along with 
myo2-D1297N, a mutant defective in binding Vac17 (Ishikawa et al., 2003). The myo2-D1297N 
mutant was included because overexpression of vac17-S222A-GFP likely interferes with the 
ability of Myo2 to transport essential cargoes (Eves et al., 2012) and did not yield viable cells. 
Cells were also transformed with a plasmid encoding Myc-ubiquitin driven under an inducible 
promoter. GFP tagged Vac17 constructs were immunoprecipitated and ubiquitylation was 
detected via immunoblotting with anti-Myc antibodies. Surprisingly, vac17-S222A-GFP was not 
ubiquitylated in vivo (Fig 2.5E). These findings indicate that phosphorylation of Vac17-S222 is 
not required for the recruitment of Dma1 to the vacuole transport complex, but must occur 
before Dma1 can ubiquitylate Vac17. Thus, phosphorylation of Vac17-S222 may spatially 
regulate the termination of vacuole transport through regulating Dma1 activity. 
 
Cla4 signaling at the bud cortex initiates the release of the vacuole from Myo2 
Cla4 localizes to the bud cortex of small-budded cells and later appears as a punctum on 
the vacuole in large-budded cells (Bartholomew and Hardy, 2009). To further analyze Cla4 
localization in relation to vacuole transport, we performed time-lapse microscopy of cells 
expressing Cla4-3xGFP and the vacuole marker Vph1-mCherry. In small budded cells, Cla4-
3xGFP appears on the bud cortex, as previously described in (Bartholomew and Hardy, 2009). A 
 32 
portion of the vacuole then enters the bud and extends to the bud cortex, where it colocalizes 
with Cla4. A punctum of Cla4 then moves onto the vacuole (Fig 2.6). These observations suggest 
that arrival of the vacuole at the bud cortex initiates Cla4 signaling on the vacuole. Additionally, 
Cla4 activity is required for proper unloading of the vacuole from Myo2. In a wild type cell, 
Vac17-GFP is barely visible and the vacuole is in the center of the cell (Fig 2.7A). In the non-
phosphorylatable vac17-S222A mutant, the vacuole and vac17-S222A-GFP persist at the bud tip 
and eventually move from the bud tip to the mother-bud neck (Fig 2.7B). In further support 
that Cla4 is acting at the cortex, we find that the Cla4 homologue, Ste20 partially substitutes for 
Cla4 (Fig 2.1D-E), yet Ste20 is solely at the bud cortex (Peter et al., 1996; Takahashi and Pryciak, 
2007). Together, these findings suggest that PAKs signal the release of the vacuole from Myo2 
at the bud cortex.  
To determine if Cla4 and Vac17 colocalize at the bud cortex, we analyzed the localization 
of Cla4-tdTomato and Vac17-GFP expressed in the cla4∆vac17∆ mutant via synchronization 
with α-factor and imaging at 10 minute intervals. At 50 minutes after release, Cla4-tdTomato 
and Vac17-GFP co-localized at the bud cortex. At 80 minutes after release, Vac17-GFP was no 
longer detected, which is consistent with the degradation of Vac17 (Fusheng Tang, 2003; Peng 
and Weisman, 2008). Additionally, even though Vac17 was degraded, a punctum of Cla4 was 
observed on the vacuole as previously described (Bartholomew and Hardy, 2009) (Fig 2.8Aand 
Fig 2.9). We then analyzed the dynamics of Cla4-tdTomato and vac17-S222A-GFP. In contrast to 
wild type, Cla4 and Vac17 colocalized 60 minutes after release. At 80 minutes after release, 
vac17-S222A-GFP accumulated with the vacuole at the bud tip while a punctum of Cla4 
localized to a different area of the vacuole. At 120 minutes after release, vac17-S222A-GFP mis-
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localized with the vacuole at the mother-bud neck (Fig 2.8B and Fig 2.9). These data suggest 
that a transient interaction between Cla4 and Vac17 at the leading edge of the vacuole occurs 
after the vacuole reaches the bud cortex. Moreover, when Cla4 fails to phosphorylate vac17-
S222A, vac17-S222A and the vacuole persist at the bud cortex before mis-localizing to the 
mother-bud neck (Fig 2.8B and 2.8B). These data suggest that Cla4 phosphorylates Vac17-S222 
upon arrival of the vacuole at the bud cortex, triggering Vac17 degradation and release of the 
vacuole from Myo2. 
 
Discussion 
These studies reveal that Cla4 provides spatial control for the termination of vacuole 
transport (Fig 2.10). Our studies indicate that the bud cortex is the landmark that signals the 
successful delivery of a myosin V cargo to its correct intracellular location. We show that 
contact between Cla4 and Vac17 at the bud cortex (Fig 2.6) initiates the termination of vacuole 
transport. Cla4 directly regulates Vac17 degradation via phosphorylating Vac17-S222 (Fig 2.3). 
Intriguingly, phosphorylation by Cla4 is required for the ubiquitylation and degradation of 
Vac17 (Fig 2.4 and 2.5), but not for the recruitment of Dma1 to the vacuole (Fig 2.5). Together, 
these studies suggest that once the vacuole reaches the bud cortex, Cla4 initiates a signaling 
cascade that activates Dma1 to ubiquitylate Vac17 and complete the termination of vacuole 
inheritance. Vac17-S222 phosphorylation may change the conformation of Vac17 so that it is 
amenable for Dma1-dependent ubiquitylation or recruit a binding partner that activates Dma1. 
These roles for Cla4 in Myo2 transport suggest a direct molecular link between cell polarity 
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factors and the positioning of organelles. Our studies reveal that myosin V relies on a spatially 
regulated signaling cascade to successfully transport of cargoes to their correct destinations.  
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Figure 2.1. Deletion of Cla4 or Ste20 causes a partial defect in the termination of vacuole 
transport.  
A) Large budded lte1Δ cells do not exhibit accumulation of the vacuole at the bud tip 
(arrowhead) and mother-bud neck (arrow) compared to dma1Δ cells. Scale bar = 5μm  
B) Quantification of >20 large budded cells per strain per n.  
C) The lte1Δ mutant does not have elevated levels of Vac17 as indicated by western blot. Pgk1; 
loading control. Representative of n=3  
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D) Vac17 levels are similar in wild type, ste20Δ, and cla4Δ cells. Pgk1; loading control.  
E) Large budded ste20Δ and cla4Δ cells exhibit a partial accumulation of Vac17-GFP and the 
vacuole at the bud tip (arrowhead) and mother-bud neck (arrow). Scale bar = 5μm  
F) Quantification of >50 large budded cells per strain per n. (B, F). Error bars; SEM, n=3. * = 
p<0.05, ** =p<0.01, two-tailed Student’s t-test. 
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Figure 2.2. PAKs are required for the degradation of Vac17 and the release of the vacuole 
from Myo2.  
A) Vac17 levels are elevated in dma1Δ and ste20Δ cla4ts mutants. The ste20Δ cla4ts mutant was 
grown at either 24°C or shifted to 37°C for 3 hours prior to lysis. Pgk1; loading control.  
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B-E) Loss of PAK function results in mis-localization of the vacuole (FM4-64)  
B, D) and accumulation of Vac17-GFP (B) at the bud tip (arrowheads) or mother-bud neck 
(arrows). Wild type and ste20Δ cla4ts cells transformed with Vac17-GFP (B) or Myo2-Venus (D). 
After FM4-64 labeling, cells were chased at 24°C for 3 hours or 24°C for 90 minutes and then 
37°C for 90 minutes prior to imaging. Scale bar = 5μm.  
C, E) Quantification of > 35 large budded cells per condition per n. Error bars; SEM, n=3. * = 
p<0.05, ** =p<0.01, two-tailed Student’s t-test. 
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Figure 2.3. Cla4 binds and phosphorylates Vac17.  
A) Purified recombinant GST-Cla4, but not GST alone, binds Vac17-TAP from dma1Δ dma2Δ 
VAC17-TAP lysates.  
B) The anti-pS222 antibody recognizes wild type Vac17-GFP but not the vac17-S222A-GFP 
mutant.  
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C) λ-phosphatase treatment causes an increase in the electrophoretic mobility of Vac17-GFP 
and ablates detection by the anti-pS222 antibody.  
D) Inactivation of PAKs decreases the phosphorylation of Vac17-S222 and to a lesser extent, 
Vac17-T240. Vac17 phosphorylation monitored using anti-pS222 or anti-pT240 antibodies in the 
ste20 cla4ts mutant transformed with Vac17-GFP. Cells were grown at 24°C or shifted to 37°C 
for 3 hours prior to immunoprecipitation of Vac17-GFP using anti-GFP antibodies. As a positive 
control, Vac17-GFP immunoprecipitated from a dma1Δ mutant is phosphorylated at both sites.  
E) Levels of pT240 or pS222 were normalized to GFP and those ratios were normalized to 
dma1∆. Error bars; SEM, n=2. * = p<0.05, two-tailed Student’s t-test.  
F) 6xHIS-Vac17 (96-355), but not 6xHIS-vac17-S222A (96-355) is phosphorylated by Cla4, but 
not the kinase dead cla4-K594A mutant or in the absence of ATP. Phosphorylation analyzed via 
immunoblotting with the anti-pS222 antibody.  
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Figure 2.4. Termination of vacuole transport initiates at the bud cortex.  
Fluorescence microscopy of a vac17Δ strain transformed with plasmids encoding GFP tagged 
VAC17 or vac17 point mutants with or without mCherry or Venus tagged Myo2. Error bars; 
SEM, n=3. * = p<0.05, ** =p<0.01, two-tailed Student’s t-test. Scale bar = 5μm.  
A) vac17-S222A-GFP and vac17-T240A-GFP resulted in mis-localization of the vacuole (FM4-64) 
to the bud tip (arrowheads) or mother-bud neck (arrows).  
B) Quantification of >30 large budded cells per strain per n.   
C) Vacuoles colocalize with Myo2-Venus at the bud tip (arrowheads) or mother-bud neck 
(arrows) in cells expressing vac17-S222A or vac17-T240A.  
D) Quantification of >40 large budded cells per strain per n for the colocalization of Myo2 and 
the vacuole.   
E) Quantification of >40 large budded cells per strain per n for the localization of Myo2.  
F) vac17-S222A-GFP and vac17-T240A-GFP colocalize with mCherry-Myo2 at the bud tip 
(arrowheads) or mother-bud neck (arrows).   
G) Quantification of >58 large budded cells per strain per n for the colocalization of Myo2 and 
Vac17.  
H) Quantification of >58 large budded cells per strain per experiment for the localization of 
Myo2. 
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Figure 2.5. vac17-S222A-GFP and the vacuole travel from the bud tip to the mother-bud neck. 
Time lapse microscopy of cells expressing Vac17-GFP (A) or vac17-S222A-GFP (B) were labeled 
with FM4-64 (vacuole,) and imaged every 2 minutes. Representative time lapse from n=3.  
A) In wild type, Vac17-GFP disappears and the vacuole is in the center of the bud.  
B) In the vac17-S222A-GFP mutant that cannot be phosphorylated, the vacuole and vac17-
S222A-GFP travel from the bud tip to the mother-bud neck.  
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Figure 2.6. Vac17-S222 is required for the ubiquitylation of Vac17.  
A) Phosphorylation of Vac17-S222 and Vac17-T240 are independent of each other.  
B) Levels of pT240 or pS222 were normalized to GFP and those ratios were normalized to wild 
type. Error bars; SEM, n=3. ** = p<0.01, two-tailed Student’s t-test.  
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C) Dma1 recruitment to the vacuole (FM4-64) (arrows) does not require Vac17-S222. Wild type 
VAC17 or vac17 point mutants expressed from plasmids in a DMA-3xGFP vac17Δ strain. Scale 
bar = 5μm.  
D) Quantification of >21 cells per strain per n. Error bars; SEM, n=3. ** =p<0.01, two-tailed 
Student’s t-test.  
E) The vac17-S222A mutant is not ubiquitylated in vivo. vac17Δ and dma1Δdma2Δvac17Δ cells 
were co-transformed with a plasmid encoding myc-ubiquitin under a copper inducible 
promoter and plasmids encoding GFP tagged VAC17 or vac17-S222A. GFP tagged proteins were 
immunoprecipitated using anti-GFP antibodies. Ubiquitylation detected via immunoblotting 
with anti-myc antibody. Pgk1; loading control.
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Figure 2.7. Cla4 localizes to the vacuole after the vacuole contacts the bud cortex.  
Time lapse microscopy of cells expressing endogenous Cla4-3xGFP and Vph1-mCherry (vacuole) 
shows that the vacuole extends to the bud cortex and acquires a puncta of Cla4 (arrowheads). 
Representative time course from n=5. Scale bar = 5μm. Note that due to issues with photo 
bleaching, we chose time courses where the vacuole had crossed the mother-bud neck at time 
0.  
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Figure 2.8. The initiation of Cla4 signaling at the vacuole occurs at the bud cortex. 
cla4Δvac17Δ mutant transformed with Cla4-tdTomato and either Vac17-GFP or vac17-S222A-
GFP. Cells synchronized with α-factor were imaged every 10 minutes after release. 
Representative images from >25 cells per strain per time point per n. n=3. Scale bar = 5μm.  
A) Cla4-tdTomato colocalized with Vac17-GFP at the bud cortex (arrowheads). After Vac17-GFP 
is no longer detected, Cla4-tdTomato is localized away from the cortex (yellow arrow).  
B) Cla4-tdTomato and vac17-S222A-GFP colocalized at the bud cortex (arrowheads). vac17-
S222A-GFP persisted at the bud tip (white arrow) and later the mother-bud neck (blue arrow) 
after Cla4-tdTomato localized to a different location on the vacuole (yellow arrow).  
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Figure 2.9. Cla4 co-localizes with Vac17 and the vacuole at the bud cortex. 
cla4Δvac17Δ mutant transformed with Cla4-tdTomato and either Vac17-GFP or vac17-S222A-
GFP. 
A) Quantification of >25 cells per strain per time point per n, n=3.  
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B) Cla4-tdTomato colocalized with Vac17-GFP or vac17-S222A-GFP and the vacuole (CMAC) in 
small budded cells (arrowheads). In large budded cells, vac17-S222A-GFP colocalized with the 
vacuole at the bud tip (white arrow) or mother-bud neck (blue arrow), while Cla4-tdTomato 
localized on the vacuole at a different location (yellow arrow). Representative images of >30 
cells per strain per n, n=3. Scale bar = 5μm. Schematics in right column refer to time courses in 
(A). 
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Figure 2.10. Cla4 spatially regulates the ubiquitylation of Vac17 
Myo2 brings a portion of the vacuole and Vac17 to the bud cortex where Cla4 phosphorylates 
Vac17. A punctum of Cla4 then moves onto the vacuole. Cla4-dependent phosphorylation of 
Vac17 may either recruit a downstream binding partner or change the conformation of Vac17 
to facilitate Dma1-dependent ubiquitylation of Vac17 and thus the termination of vacuole 
transport. 
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CHAPTER III 
CARGO RELEASE FROM MYOSIN V REQUIRES THE CONVERGENCE OF PARALLEL PATHWAYS 
THAT PHOSPHORYLATE AND UBIQUITYLATE THE CARGO ADAPTOR 
 
The work in this chapter is currently in revision as follows: Wong, S., Hepowit, N.L., Port, S.A., 
Yau, R.G., Peng, P., Azad, N., Habib, A., Harpaz, N., Schuldiner, M., Hughson, F.M., MacGurn, 
J.A., and Weisman, L.S. (2020) Current Biology, accepted pending minor revisions.  
 
S.W. designed the experiments, conducted the experiments, and wrote the paper. N.H. and 
J.M. conducted the SILAC experiments. S.A.P. and F.M.H. constructed the recombinant Vps41 
and designed the purification method. R.G.Y. conducted experiments using the phospho-
specific antibodies. Y.P. conducted experiments testing the Yck3 deletion mutant. N.A. 
conducted experiments testing the Vps39 deletion mutant. A.H. conducted experiments testing 
Vps41 binding to Vac17. N.H., and M.S. conducted experiments with the Vps41 deletion 
mutant. L.S.W. designed the experiments and wrote the paper.
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Introduction 
Myosin V motors transport organelles to their correct intracellular locations. In 
Saccharomyces cerevisiae, a myosin V, Myo2, transports the vacuole (Kent L. Hill, 1996; Natalie 
L. Catlett, 1998), mitochondria (Simon et al., 1995), peroxisomes (Hoepfner et al., 2001), 
secretory vesicles (Pruyne et al., 1998), Golgi (Arai et al., 2008), astral microtubules (Hwang et 
al., 2003; Lee et al., 2000; Liakopoulos et al., 2003; Miller et al., 2000; Yin et al., 2000), and lipid 
droplets (Knoblach and Rachubinski, 2014) to the bud during cell division. Transport initiates 
when myosin V binds to cargo-specific adaptors and attaches to organelles (Knoblach and 
Rachubinski, 2016; Weisman, 2006; Westermann, 2014). Upon arrival at their correct locations, 
organelles are detached from myosin V, thereby terminating transport. 
 Vacuole transport in yeast is a highly regulated process. The vacuole-specific 
cargo adaptor, Vac17, physically links Myo2 to the vacuole (Ishikawa et al., 2003; Tang et al., 
2003). Early in the cell cycle, Vac17 is phosphorylated by Cdk1, which facilitates Vac17 
association with Myo2 (Peng and Weisman, 2008). Vac17 binds to the vacuole via Vac8, a 
protein associated with the vacuole membrane, via myristoylation and palmitoylation (Tang et 
al., 2006; Wang et al., 2001; Yong-Xu Wang, 1998). Formation of the Myo2-Vac17-Vac8 complex 
bridges the vacuole to Myo2, and allows a portion of the vacuole to be brought into the 
growing bud. Later in the cell cycle, Myo2 is released from the vacuole via the regulation of 
Vac17. Upon arrival at the bud cortex, a bud-cortex localized kinase, Cla4, phosphorylates 
Vac17 (Yau et al., 2017). This spatial cue signals the proper delivery of the vacuole to the bud. 
Vac17 is then ubiquitylated by the E3 ligase Dma1, which targets Vac17 for degradation by the 
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proteasome (Yau et al., 2017). In mutants where Vac17 is not degraded, Myo2 is not released 
from the vacuole (Tang et al., 2003; Yau et al., 2017).  
It was previously assumed that ubiquitylation is both necessary and sufficient for the 
termination of vacuole transport. In that scenario, ubiquitylated Vac17 would be degraded from 
within the Myo2-Vac17-Vac8 complex and this would be sufficient to release Myo2 from the 
vacuole. As an alternative, there may be specific mechanisms to dissociate the Myo2-Vac17-
Vac8 complex to release Myo2 from the vacuole, and then the released ubiquitylated Vac17 
would be degraded by the proteasome.  
Here, we report a pathway that functions in parallel with the ubiquitylation of Vac17 to 
dissociate Vac17 from the Myo2-Vac17-Vac8 complex. We show that the homotypic fusion and 
protein-sorting (HOPS) subunit, Vps41, regulates an unknown kinase to phosphorylate Vac17. In 
addition, the vacuole-localized Casein Kinase I, Yck3, is responsible for phosphorylation of a 
subset of the Vps41-dependent sites and Vps41 may directly regulate Yck3 as well. Importantly, 
we show that these phosphorylation sites on Vac17 are required for the release of Vac17 and 
its delivery to the proteasome for its subsequent degradation. However, Myo2 and Vac8 are 
not degraded and remain in their original locations, sites of polarized growth and the vacuole, 
respectively. This suggests that Vps41 and Yck3 regulate the dissociation of ubiquitylated Vac17 
from the motor-adaptor complex. We find that ubiquitylation of Vac17 can occur 
independently of phosphorylation of the sites that require Vps41 or Yck3. Conversely, Vps41 
and/or Yck3 -dependent phosphorylation can occur without ubiquitylation. However, both the 
Vps41 and Yck3 -dependent pathways and the ubiquitylation pathway are required together for 
the vacuole to be released from Myo2 and for Vac17 to be degraded. That parallel pathways 
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must converge to release Myo2, demonstrates that multiple signals are required to terminate 
vacuole inheritance. We predict that the association of Myo2 with other cargo adaptors, as well 
as the association of other myosin V motors with their cargo, undergo similar types of 
regulation. These studies reveal that the termination of cargo transport is tightly controlled and 
likely critical to cellular health and function. 
 
Results 
Yck3 and Vps41 regulate the termination of vacuole transport  
 Vac17 is highly phosphorylated (Ishikawa et al., 2003; Peng and Weisman, 2008; Tang et 
al., 2003; Yau et al., 2014; Yau et al., 2017). Some of the previously identified phosphorylation 
sites promote the assembly of the Myo2-Vac17-Vac8 complex, while other sites in Vac17 are 
required for the termination of vacuole transport. We reasoned that currently unknown 
regulatory sites in Vac17, and/or the discovery of related kinases, have the potential to reveal 
additional essential steps for the termination of vacuole transport. 
 We hypothesized that a vacuolar kinase may regulate vacuole transport. Yck3 is one of a 
few kinases that is constitutively localized on the vacuole (Sun et al., 2004). Moreover, Yck3-
dependent phosphorylation of some of its targets releases them from protein complexes on the 
vacuole membrane (Hickey et al., 2009; Lawrence et al., 2014). These studies raised the 
possibility that Yck3 may have a role in the regulated disassembly of the Myo2-Vac17-Vac8 
complex.  
 We tested and found that a yck3∆ mutant results in the accumulation of Vac17-GFP and 
the vacuole at the bud tip and mother-bud neck (Figure 3.1A). Since these two distinct 
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phenotypes appear in a similar percentage of cells, we show representative images of both. 
These phenotypes are similar to a dma1∆ mutant which exhibits defects in the disassociation of 
the Myo2-Vac17-Vac8 complex and the turnover of Vac17. Additionally, deletion of Yck3 results 
in elevated levels of endogenous Vac17, similar to the dma1∆ mutant (Figure 3.1B), which 
further suggests that there is a block in the turnover of Vac17. These studies strongly suggest 
that Yck3 has a role in the termination of vacuole transport. Although it was previously 
reported that Yck3 may have a role in the initiation of vacuole transport (LaGrassa and 
Ungermann, 2005), we only observed a defect in the termination of vacuole transport in the 
strain backgrounds used in this study. 
 We then tested if Vps41 also has a role in the termination of vacuole transport.  Vps41 is 
a subunit of the HOPS complex (Nakamura et al., 1997; Radisky et al., 1997; Seals et al., 2000; 
Ungermann et al., 2000; Wada et al., 1992), and in this capacity is required for fusion of 
endosomes with the vacuole, and vacuole-vacuole fusion (Seals et al., 2000; Ungermann et al., 
2000; van der Beek et al., 2019). Importantly, Vps41 is a downstream target of Yck3 during 
vacuole fusion (Cabrera et al., 2009; LaGrassa and Ungermann, 2005). Yck3 phosphorylates 
Vps41 to negatively regulate its role in the HOPS complex (Cabrera et al., 2010; Cabrera et al., 
2009; LaGrassa and Ungermann, 2005).  
 Notably, we found that deletion of Vps41 resulted in the accumulation of the vacuole 
and Vac17-GFP at the bud tip and mother-bud neck (Figure 3.1A), and also resulted in elevated 
levels of endogenous Vac17 (Figure 3.1B). These phenotypes are similar to those observed in 
the yck3∆ and dma1∆ mutants. Note that the vps41∆ mutant has fragmented vacuoles due to 
the role of Vps41 in vacuole fusion (Nakamura et al., 1997; Radisky et al., 1997; Seals et al., 
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2000; Ungermann et al., 2000; Wada et al., 1992). Moreover, the yck3∆vps41∆ double mutant 
showed similar phenotypes to the yck3∆ and vps41∆ single mutants (Figure 3.1A, 3.1B). These 
data indicate that both Yck3 and Vps41 have roles in the termination of vacuole transport. 
 In further support that Vps41 and Yck3 are both required to release the vacuole from 
Myo2, similar to a dma1∆ mutant, the vacuole accumulates at the bud tip and mother-bud neck 
with Myo2-Venus in the vps41∆, yck3∆, and yck3∆vps41∆ mutants (Figure 3.2A). Additionally, 
similar to a dma1∆ mutant, Vac17-GFP accumulates at the bud tip and mother-bud neck with 
mCherry-Myo2 in the vps41∆, yck3∆, or yck3∆vps41∆ mutants (Figure 3.2B). Together, these 
data provide additional support for the hypothesis that both Vps41 and Yck3 are required for 
the release of the vacuole from Myo2 and the subsequent degradation of Vac17.  
 
The roles of Yck3 and Vps41 in the termination of vacuole transport are independent of the 
HOPS complex, CORVET complex, and AP-3 trafficking  
 Yck3 was previously shown to regulate Vps41 through the phosphorylation of four sites: 
S367, S368, S371, and S372 (Cabrera et al., 2009; LaGrassa and Ungermann, 2005). In the 
context of HOPS function in endosome fusion with the vacuole, a non-phosphorylatable mutant 
phenocopies the yck3∆ mutant and results in the localization of Vps41 to the vacuole, while the 
phosphomimetic mutant displaces Vps41 from the vacuole (Cabrera et al., 2009). We tested if 
the non-phosphorylatable and/or phosphomimetic Vps41 mutants had defects in the 
termination of vacuole transport. While these mutants block HOPS function, they support the 
termination of vacuole transport (Figure 3.3A). Although there is a modest increase in 
accumulation of Vac17 at the bud tip, neither the non-phosphorylatable nor the 
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phosphomimetic Vps41 mutants recapitulated the vps41∆ mutant. This raises the possibility 
that the roles of Yck3 and Vps41 in vacuole transport are separate from their roles in the HOPS 
complex. Two previous studies also suggested that Vps41 has functions independent of the 
HOPS complex (Asensio et al., 2013; Pols et al., 2013). 
 We tested if other HOPS subunits are also required for the termination of vacuole 
transport. We found that Vps39, the other HOPS-specific subunit, does not have a role in the 
termination of vacuole transport. The vps39∆ mutant did not result in the accumulation of 
Vac17-GFP at the bud tip or mother-bud neck (Figure 3.3B), and did not have elevated levels of 
Vac17 by western blot (Figure 3.3C). 
 The other four HOPS subunits, Vps11, Vps16, Vps18, and Vps33, are also found in the 
class C core vacuole/endosome tethering (CORVET) complex, another vesicle tether complex 
(van der Beek et al., 2019). It was previously reported that loss of function of these core 
subunits results in defects in the initiation of vacuole transport (Banta et al., 1990). Thus, we 
only scored cells that inherited vacuoles. By microscopy, there was neither an accumulation of 
Vac17-GFP nor mis-localization of the vacuole in temperature sensitive mutants of Vps11, 
Vps16, Vps18, or Vps33 (Figure 3.4). These findings indicate that the other HOPS subunits are 
not required for release of the vacuole from Myo2, suggesting novel roles of Vps41 and Yck3 
that are independent of their known roles in HOPS. 
 Vps41 also has roles in adaptor protein-3 (AP-3) vesicle trafficking, which is required for 
the ALP pathway that traffics proteins to the vacuole (Angers and Merz, 2009; Cabrera et al., 
2010; Darsow et al., 2001; Rehling et al., 1999). Vps41 may also form intermediate complexes 
with Vps3 (Peplowska et al., 2007), suggesting a link to CORVET specific subunits. Neither 
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deletion of AP-3 components Apl5, Ap3, Apl6, and Apm3, nor deletion of CORVET specific 
subunits, Vps3 and Vps8, resulted in defects in the termination of vacuole transport (Figure 
3.5). Thus, Vps41 and Yck3 likely act independently of HOPS and CORVET and likely have 
uncharacterized roles in targeting the Myo2-Vac17-Vac8 complex to terminate vacuole 
transport. 
 
The roles of Yck3 and Vps41 are independent of the ubiquitylation of Vac17 
 Ubiquitylation of Vac17 is required for the degradation of Vac17 and the release of the 
vacuole from Myo2 (Yau et al., 2014; Yau et al., 2017). Thus, we tested whether Yck3 and Vps41 
have roles in the ubiquitylation of Vac17. The ubiquitylation of Vac17 requires several steps: 1) 
the phosphorylation of Vac17-T240, which leads to 2) the recruitment of inactive Dma1 to 
Vac17, 3) the vacuole is then brought to the bud cortex where Cla4 phosphorylates Vac17-S222, 
which leads to 4) activation of Dma1 and the ubiquitylation of Vac17. Abolishing any of the 
above steps prevents the ubiquitylation of Vac17, and thus results in defects in the termination 
of vacuole transport (Yau et al., 2014; Yau et al., 2017). 
 We tested and found that Dma1 is recruited to the vacuole in the vps41∆ and yck3∆ 
mutants. In small-budded cells, Dma1-GFP localizes to the leading edge of the vacuole in the 
vps41∆ and yck3∆ mutants, similar to yeast with wild type VPS41 and YCK3 genes (Figure 3.6A). 
Moreover, the phosphorylation of Vac17-T240, a prerequisite of Dma1 binding, occurs in wild 
type and the yck3∆ mutant, but not the non-phosphorylatable vac17-T240A mutant (Figure 
3.6B). Note that a dma1∆dma2∆ mutant was used to elevate Vac17 levels to facilitate detection 
by the phospho-specific antibody.  
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 We also found that Cla4 is recruited to the vacuole in the vps41∆ and yck3∆ mutants 
(Figure 3.6C). In small-budded cells, Cla4 is localized on the bud cortex (Bartholomew and 
Hardy, 2009). After the vacuole contacts the cortex, a punctum of Cla4 localizes to the vacuole 
(Bartholomew and Hardy, 2009). Our previous studies indicated that Cla4 likely phosphorylates 
Vac17-S222 when the vacuole reaches the bud cortex (Yau et al., 2017). We tested if Yck3 and 
Vps41 affect the ability of Cla4 to target Vac17. In small-budded vps41∆ and yck3∆ mutants, 
Cla4-GFP co-localizes with the vacuole, similar to wild type (Figure 3.6C). Vac17-S222, the target 
of Cla4, is phosphorylated in wild type and the yck3∆ mutant, but not in the non-
phosphorylatable vac17-S222A mutant (Figure 3.6B). Together, these data support the finding 
that the localization of Dma1 and activity of Cla4 are not affected by loss of Yck3 and Vps41 
(Figure 3.6A-C).  
 That Dma1 is recruited to the vacuole and that Cla4 is able to phosphorylate Vac17-S222 
strongly suggests that Vac17 is ubiquitylated. To test this hypothesis, Vac17-GFP was 
overexpressed in vac17Δ, vac17Δdma1Δdma2Δ, vac17Δyck3Δ, and vac17Δvps41Δ cells. Cells 
were also transformed with a plasmid encoding Myc-ubiquitin controlled by a copper-inducible 
promoter. Vac17-GFP was immunoprecipitated and ubiquitylation was detected via 
immunoblot with anti-Myc antibodies. Indeed, Vac17 is ubiquitylated in the vps41∆ and yck3∆ 
mutants (Figure 3.6D). These data show that Yck3 and Vps41 functions are independent of 
Vac17 ubiquitylation, and that Vac17 ubiquitylation does not require Yck3 and Vps41. 
Importantly, these data reveal that ubiquitylation of Vac17 is not sufficient to disrupt the 
complex.  
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 Previous hypotheses assumed that ubiquitylation was the last step prior to the 
degradation of Vac17. Our studies indicate that at least two independent, non-redundant 
pathways are required to dissociate the vacuole from Myo2 and degrade Vac17. Yck3 and 
Vps41 function independently of Cla4 and Dma1, yet ubiquitylation is independent of the 
pathway(s) governed by Vps41 and/or Yck3 that are required for Vac17 degradation. Since 
Dma1-dependent ubiquitylation was not impaired, these findings raise the possibility that Yck3 
and Vps41 act in another manner on Vac17 to regulate the termination of vacuole transport. 
 
Yck3 and Vps41 regulate the release of ubiquitylated Vac17 from the Myo2-Vac17-Vac8 
complex 
 Since ubiquitylation alone is not sufficient to release Myo2 from the vacuole, we turned 
to a genetic approach to determine whether Yck3 and Vps41 function with the proteasome to 
degrade Vac17, or whether they are required upstream of the proteasome. As assessed by 
western blot, loss of function proteasome mutants result in elevated levels of Vac17 (Yau et al., 
2014). However, the localization of accumulated Vac17 in these mutants was not determined.  
Notably, we found that Vac17 is released from the vacuole in several proteasome mutants, 
including the pup1-K58E pup3-E151K mutant (Figure 3.7A), as well as the pre2-T76A and pre1-1 
mutants (Figure 3.8). Pup1, Pup3, Pre1, and Pre2 comprise Beta subunits of the 20S core 
particle of the proteasome (Arendt and Hochstrasser, 1997; Chen and Hochstrasser, 1996). In 
each of the 20S proteasome mutants tested, Vac17-GFP appears in puncta that are not strictly 
on the vacuole or at the bud tip or mother-bud neck (Figure 3.7A, Figure 3.8). These findings 
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suggest that Vac17 is released from the vacuole, and likely from the Myo2-Vac17-Vac8 
complex, before Vac17 is degraded by the proteasome. 
 The phenotype of Vac17 puncta in proteasome mutants is distinct from mutants where 
Vac17 is trapped in the Myo2-Vac17-Vac8 complex and Vac17 accumulates solely at the bud tip 
or mother-bud neck. Thus, we performed epistasis experiments where the phenotype of the 
double mutant indicates the first step where a pathway is blocked. Strikingly, the double 
mutants with mutations in the proteasome combined with deletion of either Yck3 or Vps41 
phenocopy the single yck3∆ or vps41∆ mutants where Vac17 accumulates with the vacuole at 
the bud tip or mother-bud neck (Figure 3.7A). These findings show that Yck3 and Vps41 act 
upstream of the proteasome.  
 The observation that Vac17 is released from the vacuole in the proteasome mutants 
raised the question of whether Myo2 and/or Vac8 are also delivered to the proteasome. 
However, Myo2 and Vac8 levels are not elevated or reduced in the pup1-K58E pup3-E151K 
alone or in combination with the yck3∆ or vps41∆ mutants by western blot (Figure 3.7B). This is 
in contrast to Vac17-GFP, which is elevated in the pup1-K58E pup3-E151K and/or yck3∆ or 
vps41∆ mutants to a similar extent when compared to wild type (Figure 3.7B). Additionally, 
neither Myo2 nor Vac8 accumulate in puncta in the proteasome mutant. We found that the 
localization of Myo2-Venus (Figure 3.9A) and Vac8-mCherry (Figure 3.9B) are not perturbed in 
the pup1-K58E pup3-E151K mutant. Note that CMAC, a small molecule that stains the lumen of 
the vacuole (Stefan and Blumer, 1999; Stewart and Deacon, 1995), was used as a vacuole 
marker when we tested Vac8 localization on the vacuole membrane. Overall, these data 
indicate that Yck3 and Vps41 act upstream of the proteasome to dissociate ubiquitylated Vac17 
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from the Myo2-Vac17-Vac8 complex on the vacuole, which releases the vacuole from Myo2 
and allows for the degradation of ubiquitylated Vac17.  
 
The AAA-ATPases Cdc48/p97, Vps4, and Sec18/NSF do not extract Vac17 from the complex 
Several AAA-ATPases have been shown to extract proteins from membranes or protein 
complexes to facilitate their degradation. Cdc48/p97 extracts endoplasmic reticulum 
membrane proteins destined for degradation (Bodnar and Rapoport, 2017). Vps4 aids in the 
disruption of ESCRT-III complex on endosomes (Migliano and Teis, 2018). Sec18/NSF is AAA-
ATPase that disassembles SNARE complexes, and in this capacity also works on SNARE 
complexes at the vacuole (Lobingier et al., 2014; Song et al., 2017; Steel et al., 1999). However, 
we tested and found that a Cdc48 temperature sensitive mutant, cdc48-3, (Figure 3.10A), a 
vps4∆ mutant (Figure 3.10B), and a sec18-DAmP mutant (Figure 3.10C) did not have defects in 
the termination of vacuole transport. It is possible that a currently unidentified AAA-ATPase is 
recruited to facilitate the release of Vac17 from the Myo2-Vac17-Vac8 complex, or a different 
mechanism is required for dissociation of the complex. 
 
Yck3 and Vps41 bind and are required for the phosphorylation of Vac17 
 Our data suggest that Yck3 and Vps41 target Vac17. Consequently, we tested if Yck3 can 
bind to full-length Vac17. Since Yck3 function was not required for Cla4 or Dma1 regulation of 
Vac17, we also tested if Yck3 could bind the vac17-∆PEST mutant, which is missing the sites of 
Dma1 binding and Cla4 phosphorylation (Figure 3.11A). Recombinant GST-Yck3 (2-516) 
immobilized on beads was able to bind to Vac17-TAP and Vac17-∆PEST-TAP from yeast lysates 
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(Figure 3.11B). This indicates that Yck3 binds to Vac17 and that this interaction does not require 
the Vac17-PEST sequence. Interestingly, this interaction does not require Vps41, as GST-Yck3 
(2-516) immobilized on beads was able to bind to Vac17-∆PEST-TAP from vps41∆ yeast lysates 
(Figure 3.11B). Note that it is possible that the interaction between Yck3 and Vac17 is indirect 
and facilitated by an unknown protein present in the yeast lysates. Importantly, Yck3 and Vac17 
are in a complex together and Vac17 is thus a candidate substrate for phosphorylation that is 
either directly or indirectly regulated by Yck3.  
 We also tested if Vps41 is able to bind to Vac17. We found that recombinant His-Vps41 
(124-992) from C. thermophilium binds to Vac17-TAP and Vac17-∆PEST-TAP from yeast lysates 
(Figure 3.11C). This interaction also occurred in a yck3∆ mutant (Figure 3.11C). These data 
demonstrate that both Yck3 and Vps41 bind, either directly or indirectly, to Vac17 in regions of 
Vac17 that are outside of the Vac17-PEST sequence. Note that there may also be regions within 
the PEST sequence with the potential to bind Yck3 and/or Vps41. Importantly, previously 
known regulators, Cla4 and Dma1, regulate or bind Vac17 via the PEST sequence. That Yck3 and 
Vps41 bind Vac17-∆PEST suggests a new mode of regulation in the termination of vacuole 
transport. 
 Since Yck3 is a kinase, and the yck3∆ and vps41∆ mutants have similar phenotypes, we 
hypothesized that Yck3 and Vps41 regulate the phosphorylation of Vac17. Both Yck3 and Vps41 
are able to bind Vac17-∆PEST. Therefore, we next tested if Yck3 and/or Vps41 are responsible 
for phosphorylation of Vac17-∆PEST. Using a gel shift assay, we found that Yck3 and Vps41 -
dependent phosphorylation occurred in the vac17-∆PEST mutant. The addition of phosphatase 
collapses the higher mobility band in Vac17-∆PEST-GFP, which is rescued by phosphatase 
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inhibitors (Figure 3.11D). In the yck3∆ and vps41∆ mutants, addition of phosphatase does not 
result in any change in gel mobility, suggesting that the gel mobility shift in Vac17-∆PEST-GFP is 
due to Yck3 and Vps41 -dependent phosphorylation (Figure 3.11D).  
 We also tested if Yck3 and Vps41 –dependent phosphorylation requires an intact Myo2-
Vac17-Vac8 complex. We used western blot analysis to test the mobility of Vac17-∆PEST-GFP in 
mutants that are blocked in the formation of the motor-adaptor complex. In the myo2-D1297N 
mutant, Myo2 is unable to bind to Vac17, and Vac17 is bound to Vac8 on vacuoles that remain 
in the mother cell (Eves et al., 2012). We found in a gel shift assay that Yck3 and Vps41 -
dependent phosphorylation requires that Vac17 is bound to Myo2 or must be in the bud, as 
Vac17-∆PEST-GFP is not phosphorylated in the myo2-D1297N mutant (Figure 3.11E). Next, we 
tested a vac8∆ mutant in which Vac17 is bound to Myo2 and is brought to the bud, but is not 
associated with the vacuole (Peng and Weisman, 2008). We found that Vac17-∆PEST-GFP is not 
phosphorylated in a vac8∆ mutant, (Figure 3.11F). This suggests that Vac17 needs to be on the 
vacuole in the bud and/or in a complex with Myo2 and Vac8 to be phosphorylated by Yck3 
and/or the Vps41 pathway. These data suggest that Yck3 and Vps41 regulate the 
phosphorylation of Vac17 after the Myo2-Vac17-Vac8 complex is formed and vacuole transport 
is initiated. It remains an open possibility that it is not the complex per se, but rather that 
phosphorylation occurs if Vac17 is in the bud and on the vacuole. 
 To determine if Dma1 is required for the Yck3 -dependent phosphorylation of Vac17, we 
used a gel shift assay to determine the phosphorylation of Vac17 in several mutants. In a 
dma1∆dma2∆yck3∆ mutant, Vac17-∆PEST-GFP has increased mobility compared to a 
dma1∆dma2∆ mutant (Figure 3.11G), indicating that Dma1/Dma2 are not required for Yck3 -
 65 
dependent phosphorylation of Vac17. Of note, Vac17-∆PEST-GFP levels appear to be at lower 
levels in a dma1∆dma2∆ mutant compared to vac17-∆PEST-GFP in wild type or yck3∆ 
backgrounds (Figure 3.11G). This may be due to compensatory mechanisms that lower Vac17-
∆PEST levels in the dma1∆dma2∆ mutant. Consistent with previous data, these data overall 
suggest that Dma1-dependent ubiquitylation vs. Yck3 and/or Vps41-dependent 
phosphorylation occur through independent pathways.  
 
Yck3 and Vps41 phosphorylate Vac17 in the Myo2 binding domain  
 To determine Vps41 and Yck3 -dependent phosphosites on Vac17, we performed Stable 
Isotope Labeling by Amino acids in Cell culture (SILAC) mass spectroscopy. We identified 
multiple sites in Vac17-∆PEST whose phosphorylation status is changed in the vps41∆ mutant 
(Table 3). Interestingly, four of the Vac17 phosphosites that are reduced in the vps41∆ mutant 
reside in the Myo2 binding domain of Vac17: S127, S128, S131, and T149. One of these sites, 
S131, was also reduced in the yck3∆ mutant (Table 4).  
 We determined whether these sites are required for termination of vacuole transport 
and the degradation of Vac17 by testing the corresponding non-phosphorylatable alanine 
mutations. As assessed by microscopy, mutating all four residues to alanine resulted in a defect 
in the termination of vacuole transport similar to the yck3∆ mutant (Figure 3.12A). Alanine 
mutations in three of these sites, vac17-S127A-S128A-S131A (denoted as vac17-3A), also had a 
significant defect, while the vac17-T149A mutant on its own showed a trend that was not 
significant. Note that Vac17-T149 was identified as one of four Cdk1 sites important for the 
initiation of vacuole transport (Peng and Weisman, 2008). However, the vac17-T149A mutant 
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alone did not have defects in vacuole transport (Figure 3.12A). By western blot, mutating all 
four of these residues to alanine resulted in elevated levels of Vac17, similar to the yck3∆ 
mutant (Figure 3.12B). These data suggest that phosphorylation of these residues is required 
for the release of the vacuole from Myo2 and the degradation of Vac17. 
 We then tested the putative phosphomimetic mutant, vac17-4E. This mutant was not 
defective in the release of Myo2 from the vacuole and did not elevate levels of Vac17 (Figure 
3.12C-D, Figure 3.13A-D). Rather, the vac17-4E mutant acted like wild type, suggesting that 
phosphorylation of these residues is required for the termination of vacuole transport. 
 We further tested the vac17-4A mutant and the phosphomimetic vac17-4E mutant in 
combination with the pup1-K58E pup3-E151K proteasome mutant to determine whether these 
sites are required for the release of Vac17 from the Myo2-Vac17-Vac8 complex. Importantly, in 
the vac17-4A pup1-K58E pup3-E151K mutant, Vac17-4A-GFP accumulated at the bud tip or 
mother-bud neck instead of in puncta in the cytoplasm (Figure 3.12C). Moreover, compared to 
wild type, the vac17-4A mutant had elevated levels of Vac17, and the vac17-4A pup1-K58E 
pup3-E151K mutant elevated Vac17 to levels greater than the pup1-K58E pup3-E151K mutant 
alone (Figure 3.12D). Since the phenotype of vac17-4A pup1-K58E pup3-E151K mutant is the 
same as the vac17-4A-GFP mutant alone, these data further suggest that these phosphosites 
are important for the release of Vac17 from the Myo2-Vac17-Vac8 complex.  
 Conversely, when the vac17-4E mutant was expressed in a pup1-K58E pup3-E151K 
mutant, Vac17-4E-GFP behaved similarly to a proteasome mutant alone, and accumulated in 
puncta that were not solely localized to the vacuole (Figure 3.12C). Together these findings 
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suggest that phosphorylation of Vac17- S127, S128, S131, and T149 are required to release 
Vac17 from the Myo2-Vac17-Vac8 complex. 
 However, the vac17-4E mutant did not suppress the yck3∆ mutant (Figure 3.13A-B) or 
vps41∆ mutant (Figure 3.13C-D). This suggests that phosphorylation of these four sites are 
necessary but not sufficient for the release of Vac17 from the Myo2-Vac17-Vac8 complex, and 
that other regulatory steps are also required. Vps41 and Yck3 may have additional roles in the 
release of Vac17 from the Myo2-Vac17-Vac8 complex. These could be additional essential 
phosphorylation sites on Vac17 that were not yet identified, and/or other proteins that act in 
this pathway and require functional Vps41 and/or Yck3 for their activity in removal of Vac17 
from the Myo2-Vac17-Vac8 complex.  
 We also tested whether substitution of S127, S128, S131 and T149 with negatively 
charged residues impairs the binding of Vac17 to Myo2. While we saw a modest trend of 
increased association of Myo2 with Vac17-(1-355)-4A, and decreased association with Vac17-
(1-355)-4E, these differences were not a statistically significant (Figure 3.12E). These findings 
indicate that beyond phosphorylation of these sites, there are likely additional steps or 
regulators required for the dissociation of Vac17 from Myo2. 
 Notably, while Vps41 plays a role in the phosphorylation of Vac17 -S127, -S128, -S131, 
and –T149, deletion of Yck3 did not result in a loss of phosphorylation of Vac17 -S127, -S128 or 
T149, but exhibited a decrease in phosphorylation of Vac17-S131 (Table 4). This site matches 
the casein kinase I consensus sites, SxxS, or where the target serine or threonine is 1-3 amino 
acids downstream of acidic (Flotow et al., 1990; Marin et al., 1994; Pulgar et al., 1999) or 
primed residues (residues that have already been phosphorylated) (Cesaro and Pinna, 2015; 
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Flotow et al., 1990; Marchal et al., 2000). Thus, it is likely that Vps41 is regulating additional 
kinases, such as a potential priming kinase, to phosphorylate these sites. Overall, Vps41 
promotes the phosphorylation of the Myo2 binding domain of Vac17 likely via additional 
kinase(s) and perhaps as an upstream regulator of Yck3. 
 Additional phosphorylation sites adjacent to the Vac8 binding domain, Vac17 -S269, 
S272, and S275, were also identified (Table 3, Table 4), and importantly, these sites were 
heavily dependent on Yck3. We tested these residues for a role in vacuole transport. However, 
the non-phosphorylatable alanine mutant, vac17-S269A-S272A-S275A, did not have defects in 
the termination of vacuole transport or degradation of Vac17 (Figure 3.12E-F). Note that the 
vac17-S269A-S272A-S275A mutant exhibited a faster mobility on SDS-PAGE compared with wild 
type Vac17, suggesting that these are bona fide phosphorylation sites. These data provide 
further support to the hypothesis that in addition to these phosphorylation sites, there are 
additional steps required to release Vac17 from the Myo2-Vac17-Vac8 complex. This may be 
additional unidentified phosphorylation sites in Vac17, unidentified phosphorylation sites on 
Vac17 binding partners, and/or additional unknown regulators.  
 Overall, these data suggest that Vps41 and Yck3 are each required to regulate the 
phosphorylation of Vac17 at the interface between Vac17 and Myo2, and that this 
phosphorylation is required to dissociate Vac17 from the motor-adaptor complex. Previous 
studies of Vac17 degradation indicated that the Vac17-PEST sequence is required for the 
degradation of Vac17 and thus the termination of vacuole transport (Tang et al., 2003; Yau et 
al., 2014; Yau et al., 2017). Our new studies indicate that Yck3 and Vps41 regulate binding 
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between Vac17 and Myo2 to release ubiquitylated Vac17 from the Myo2-Vac17-Vac8 complex 
and terminate vacuole transport. 
 
Discussion 
 Our data reveal that release of the vacuole from Myo2 requires parallel pathways that 
act on the adaptor protein, Vac17. In one pathway, the bud-localized kinase, Cla4, 
phosphorylates Vac17, which facilitates the Dma1-dependent ubiquitylation of Vac17. In the 
other pathway, Yck3 and Vps41 regulate the phosphorylation of Vac17 in its Myo2 binding 
domain, and potentially other regions. Both ubiquitylation as well as Yck3 and Vps41-
dependent regulation are required to release Vac17 from the Myo2-Vac17-Vac8 complex. 
Vac17 is then degraded by the proteasome (Figure 3.14). In mutants where Yck3 and Vps41 are 
both present, but ubiquitylation of Vac17 is defective, Vac17 is not released from the complex. 
Similarly, in mutants where Vac17 is ubiquitylated but Yck3 and/or Vps41 are absent, Vac17 is 
not released from the complex. However, in loss of function proteasome mutants, where both 
ubiquitylation and Yck3 and Vps41 -dependent regulation occur, Vac17 is released from the 
vacuole, but not degraded. Vac17 levels are also elevated in the proteasome mutant where the 
Myo2-Vac17-Vac8 complex is disassembled. This suggests that elevated Vac17 alone does 
stabilize the complex. Together, these data support a model where ubiquitylation and a Yck3 
and Vps41 -dependent pathway act in parallel to dissociate the Myo2-Vac17-Vac8 complex, 
which leads to the degradation of Vac17 by the proteasome (Figure 3.14). Yck3 and Vps41 may 
function in different steps of this pathway, but a fully detailed molecular mechanism remains 
unclear.  
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 Our data strongly suggest that Vps41 acts in the release of Vac17 via regulation of 
kinase(s) that phosphorylate Vac17 in four residues within the Myo2 binding region: S127, 
S128, S131, and T149. Yck3 is one candidate kinase, which plays a role in the phosphorylation of 
Vac17-S131. An unidentified kinase may be responsible for phosphorylation of the other three 
sites. It is possible that Vps41 is regulating multiple steps in this pathway, or acts upstream of 
several kinases, and may also regulate Yck3. 
 Given the strong phenotype of yck3, it is likely that additional critical Yck3 sites within 
Vac17, Vac8, and/or Myo2, are not yet identified. While Yck3 and Vps41 are required for the 
phosphorylation of three sites in the Vac8 binding region of Vac17, the function of these sites 
are unknown and additional regulatory steps may be required. Moreover, Yck3 and/or Vps41 
may regulate the phosphorylation of residues within the Vac17-PEST sequence. The 
phosphorylation of these potentially unidentified residues may depend on the ubiquitylation 
status of Vac17 or other sites of posttranslational modifications.  
 The requirement for parallel pathways of ubiquitylation and phosphorylation leads us to 
speculate that an additional factor may act as a coincidence detector that establishes that both 
events have occurred and then allows dissociation of the complex. Such a factor may recruit 
machinery that physically releases Vac17, such as a currently untested AAA-ATPase. In budding 
yeast, there are about fifty AAA ATPases (Neuwald et al., 1999), with at least ten confirmed as 
unfolding ATPases (Vale, 2000). Alternatively, Yck3 and Vps41–dependent phosphorylation may 
change Vac17 conformation and/or work with the proteasome to dissociate Vac17 from the 
complex. 
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 The involvement of Yck3 and Vps41 raises interesting possibilities as to why and how 
Yck3 and Vps41 act independently of their known roles in the HOPS complex. These new roles 
in vacuole transport may indicate their ability to function separately from HOPS. Alternatively, 
these separate roles may link the status of vacuole function with vacuole transport.   
 A question raised by these studies is why release of Myo2 from the vacuole involves 
multiple mechanisms. Note that Myo2 transports the vacuole, a relatively large organelle, 
through the viscous, crowded cytoplasm and the narrow mother-bud neck. It is likely that 
Myo2, Vac17, and Vac8 are tightly associated with each other in the complex to prevent 
premature release of the vacuole. Thus, it makes sense that an independent pathway is 
dedicated to opening the complex. The regulated release of Myo2 from the vacuole is likely 
critical for Myo2 attachment to its essential cargo, secretory vesicles, which seal the membrane 
at the mother-bud neck during cytokinesis (Govindan et al., 1995). Degradation of free Vac17 
may be required to prevent reassembly of the complex and untimely attachment of the vacuole 
to Myo2. It is also possible that additional cues regulate the Yck3 and Vps41-dependent 
phosphorylation of Vac17 to coordinate vacuole delivery with other cellular processes, such as 
vacuole membrane fusion. Overall, these studies reveal a mechanism of how a cargo is released 
from myosin V.  To our knowledge, it remains to be determined how myosin V is released from 
other cargoes, or how cargoes are detached from other classes of molecular motors. 
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Figure 3.1. Yck3 and Vps41 are required for the termination of vacuole transport.  
A) Similar to deletion of Dma1, deletion of Yck3 and/or Vps41 results in mislocalization of the 
vacuole (FM4-64) and accumulation of Vac17-GFP at the bud tip (open arrowheads) or mother-
bud neck (closed arrows). Representative images of both phenotypes are shown. Wild type, 
dma1∆, yck3∆, vps41∆, and yck3∆vps41∆ mutant cells were transformed with pRS415-Vac17-
GFP. After FM4-64 labeling, cells were chased at 24°C for 3 h before imaging. DIC, differential 
interference contrast. Quantification of 40 large-budded cells per n, n=3. Error bars indicate 
SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
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B) Compared to wild type, endogenous levels of Vac17 are elevated in dma1∆, yck3∆, vps41∆, 
and yck3∆vps41∆ mutants. Pgk1 was used as a loading control. Molecular mass is shown in 
kilodaltons. Representative of n=3.
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Figure 3.2. Yck3 and Vps41 are required for the release of the vacuole from Myo2. 
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A) Deletion of Yck3 and/or Vps41 results in mislocalization of the vacuole (FM4-64) at the bud 
tip (open arrowheads) or mother-bud neck (closed arrows) with Myo2-Venus. Wild type, 
dma1∆, yck3∆, vps41∆, and yck3∆vps41∆ mutant cells were transformed with pRS413-Myo2-
Venus. After FM4-64 labeling, cells were chased at 24°C for 3 h before imaging. DIC, differential 
interference contrast. Quantification of 40 large-budded cells per n, n=3. Error bars indicate 
SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
B) Deletion of Yck3 and/or Vps41 results in mislocalization and accumulation of Vac17-GFP at 
the bud tip (open arrowheads) or mother-bud neck (closed arrows) with mCherry-Myo2. Wild 
type, dma1∆, yck3∆, vps41∆, and yck3∆vps41∆ mutant cells were transformed with pRS413-
mCherry-Myo2 and pRS415-Vac17-GFP. DIC, differential interference contrast. Quantification of 
40 large-budded cells per n, n=3. Error bars indicate SEM. Two-way ANOVA and Dunnett’s post-
hoc test. Scale bar = 5 µM. 
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Figure 3.3. The HOPS complex does not have a role in the termination of vacuole transport. 
A) The known Yck3-dependent phosphosites on Vps41 are not essential for the release of the 
vacuole from Vac17 or degradation of Vac17. Mutants in the Yck3-dependent phosphosites on 
Vps41 were scored for mislocalization of the vacuole (FM4-64) and accumulation of Vac17-GFP 
at the bud tip (open arrowheads) or mother-bud neck (closed arrows). vps41∆ mutant cells 
were integrated with vector, wild type, VPS41, vps41-4A, or vps41-4D, in the genome using the 
pRS406 yeast integrative vector. Strains were then transformed with pRS415-Vac17-GFP. After 
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FM4-64 labeling, cells were chased at 24°C for 3 h before imaging. DIC, differential interference 
contrast. Quantification of 40 large-budded cells per n, n=3. Error bars indicate SEM. Two-way 
ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
B) Unlike a deletion of Dma1, deletion of Vps39 does not result in mislocalization of the vacuole 
or accumulation of Vac17-GFP at the bud tip (open arrowheads) or mother-bud neck (closed 
arrows). Wild type, dma1∆, and vps39∆ mutant cells were transformed with pRS415-Vac17-
GFP. After FM4-64 labeling, cells were chased at 24°C for 3 h before imaging. DIC, differential 
interference contrast. Quantification of 40 large-budded cells per n, n=3. Error bars indicate 
SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
C) Unlike a deletion of Dma1, deletion of Vps39 does not result in elevated Vac17 levels. 
Endogenous levels of Vac17 are elevated in a dma1∆ mutant, but not in a vps39∆ mutant 
compared to wild type. Pgk1 was used as a loading control. Molecular mass is shown in 
kilodaltons. Representative of n=3. 
 78 
 
 
Figure 3.4. The core HOPS complex does not have a role in the termination of vacuole 
transport. 
Temperature sensitive mutations in Vps11, Vps16, Vps18, or Vps33 do not disrupt the 
termination of vacuole transport. Wild type, vps11-1, vps16-ts, vps18-ts, and vps33-4 mutant 
cells were transformed with pRS415-Vac17-GFP. After FM4-64 labeling, cells were chased either 
at 24°C for 3 hr or 37°C for 3 hr before imaging. DIC, differential interference contrast. 
Quantification of 40 large-budded cells per n, n=3. Error bars indicate SEM. Two-way ANOVA 
and Dunnett’s post-hoc test. Scale bar = 5 µM. 
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Figure 3.5. AP-3 and CORVET do not have roles in the termination of vacuole transport. 
AP-3 and CORVET components are not required for the termination of vacuole transport. Wild 
type, dma1∆, vps3∆, vps8∆, apl5∆, aps3∆, apl6∆, and apm3∆ mutant cells were transformed 
with pRS415-Vac17-GFP. After FM4-64 labeling, cells were chased at 24°C for 3 h before 
imaging. DIC, differential interference contrast. Quantification of 40 large-budded cells per n, 
n=3. Error bars indicate SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
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Figure 3.6. Yck3 and Vps41 are not required for the ubiquitylation of Vac17. 
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A) Dma1 is recruited to the vacuole in yck3∆ and vps41∆ mutant cells, similar to wild type 
(arrows). Wild type, yck3∆, and vps41∆ mutant cells were transformed with pRS415-Vac17-GFP. 
After FM4-64 labeling, cells were chased at 24°C for 3 h before imaging. DIC, differential 
interference contrast. Quantification of 40 small-budded cells per n, n=3. Error bars indicate 
SEM. Student’s t-test. Scale bar = 5 µM. 
B) Yck3 is not required for the phosphorylation of Vac17-S222 or Vac17-T240. dma1∆dma2∆ 
(lanes 1-4) or dma1∆dma2∆yck3∆ (lane 5) mutant cells were transformed with pRS415-Vac17-
GFP, pRS415-vac17-S222A-GFP, or pRS415-vac17-T240A-GFP. Vac17-GFP was 
immunoprecipitated with anti-GFP antibodies and analyzed via western blot. Pgk1 was used as 
a loading control. Molecular mass is shown in kilodaltons. Representative of n=3. 
C) Cla4 is recruited to the vacuole in yck3∆ and vps41∆ mutant cells, similar to wild type 
(arrows). Wild type, yck3∆, and vps41∆ mutant cells were transformed with pRS415-Vac17-GFP. 
After FM4-64 labeling, cells were chased at 24°C for 3 h before imaging. DIC, differential 
interference contrast. Quantification of 40 small-budded cells per n, n=3. Error bars indicate 
SEM. Student’s t-test. Scale bar = 5 µM. 
D) Yck3 and Vps41 are not required for the ubiquitylation of Vac17. vac17Δ (lanes 1-3), 
dma1Δdma2Δvac17Δ (lane 4), yck3∆vac17∆ (lane 5), and vps41∆vac17∆ (lane 6) mutant cells 
were co-transformed with a plasmid encoding Myc-ubiquitin under a copper-inducible 
promoter and pVT102u-Vac17-GFP. Vac17-GFP was immunoprecipitated using anti-GFP 
antibodies and analyzed via western blot. Ubiquitylation was detected via immunoblotting with 
anti-Myc antibody. Pgk1 was used as a loading control. Molecular mass is shown in kilodaltons. 
Quantification of n=3. Error bars indicate SEM. Student’s t-test. 
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Figure 3.7. Yck3 and Vps41 are required to release ubiquitylated Vac17 from the complex. 
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A) Yck3 and Vps41 act upstream of the proteasome to release Vac17 from the vacuole. In a 
proteasome mutant, Vac17-GFP accumulates in aberrant puncta (closed arrowheads). 
However, Vac17-GFP accumulates at the bud tip or mother-bud neck (closed arrows) in pup1-
K58E pup3-E51K yck3∆ and pup1-K58E pup3-E51K vps41∆ triple mutants, similar to the yck3∆ 
and vps41∆ mutants. This indicates that Yck3 and Vps41 act upstream of Pup1 and Pup3. Wild 
type, pup1-K58E pup3-E51K, yck3∆, pup1-K58E pup3-E51K yck3∆, vps41∆, and pup1-K58E pup3-
E51K vps41∆ mutant cells were transformed with pRS416-Vac17-GFP. After FM4-64 labeling, 
cells were chased at 24°C for 3 hr before imaging. DIC, differential interference contrast. 
Quantification of 40 large-budded cells per n, n=3. Error bars indicate SEM. Two-way ANOVA 
and Tukey’s post-hoc test. Scale bar = 5 µM. 
B) Myo2 and Vac8 levels are not affected by the pup1-K58E pup3-E51K, yck3∆, or vps41∆ 
mutations. Wild type was transformed with pRS416 vector (vector) or pRS416-Vac17-GFP and 
the other indicated strains were transformed with pRS416-Vac17-GFP. Vac17-GFP levels are low 
in wild type and elevated in the mutants. However, Myo2 and Vac8 levels are not elevated 
compared to wild type. Pgk1 was used as a loading control. Molecular mass is shown in 
kilodaltons. Representative of n=3. 
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Figure 3.8. Vac17 accumulates in aberrant puncta in proteasome mutants. 
A) Vac17 predominately accumulates in proteasome mutants in aberrant puncta (closed 
arrowheads). Wild type (PRE2) and pre2-T76A mutant cells were transformed with pRS415-
Vac17-GFP. After FM4-64 labeling, cells were chased at 24°C for 3 hr before imaging. DIC, 
differential interference contrast. Quantification of 40 large-budded cells per n, n=3. Error bars 
indicate SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
B) Vac17 accumulates in aberrant puncta (closed arrowheads) in a Pre1 temperature sensitive 
mutant. Wild type and pre1-1 mutant cells were transformed with pRS416-Vac17-GFP. After 
FM4-64 labeling, cells were chased at 24°C for 3 hr or 37°C before imaging. DIC, differential 
interference contrast. Quantification of 40 large-budded cells per n, n=3. Error bars indicate 
SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
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Figure 3.9. Myo2 and Vac8 are not affected in the proteasome mutant. 
A) Detachment of Myo2 from the vacuole likely does not require the proteasome. Wild type, 
pup1-K58E pup3-E51K, yck3∆, pup1-K58E pup3-E51K yck3∆, vps41∆, and pup1-K58E pup3-E51K 
vps41∆ mutant cells were transformed with pRS413-Myo2-Venus. Myo2-Venus localized to the 
bud tip or mother-bud neck (closed arrows) similar to wild type and unlike Vac17-GFP (Fig 5B). 
After FM4-64 labeling, cells were chased at 24°C for 3 hr before imaging. DIC, differential 
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interference contrast. Quantification of 40 large-budded cells per n, n=3. Error bars indicate 
SEM. Two-way ANOVA and Dunnet’s post-hoc test. Scale bar = 5 µM. 
B) Yck3 and Vps41 do not regulate Vac8 localization on the vacuole. Wild type, pup1-K58E 
pup3-E51K, yck3∆, pup1-K58E pup3-E51K yck3∆, vps41∆, and pup1-K58E pup3-E51K vps41∆ 
mutant cells were transformed with pRS413-Vac8-mCherry. After labeling with CMAC, cells 
were chased at 24°C for 30 min before imaging. DIC, differential interference contrast. 
Quantification of 40 large-budded cells per n, n=3. Error bars indicate SEM. Two-way ANOVA 
and Dunnet’s post-hoc test. Scale bar = 5 µM. 
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Figure 3.10. Cdc48, Vps4, and Sec18 are not required for the termination of vacuole transport.  
A) Cdc48 is not required for the degradation of Vac17. Wild type or cdc43-3 mutant cells were 
transformed with pRS415-Vac17-GFP. After FM4-64 labeling, cells were chased either at 24°C 
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for 3 hr or 37°C for 3 hr before imaging. DIC, differential interference contrast. Quantification of 
40 large-budded cells per n, n=3. Error bars indicate SEM. Two-way ANOVA and Tukey’s post-
hoc test. Scale bar = 5 µM. 
B) Vps4 is not required for the degradation of Vac17. Wild type or vps4∆ mutant cells were 
transformed with pRS415-Vac17-GFP. After FM4-64 labeling, cells were chased for 3 hr before 
imaging. DIC, differential interference contrast. Quantification of 40 large-budded cells per n, 
n=3. Error bars indicate SEM. Two-way ANOVA and Sidak’s multiple comparison. Scale bar = 5 
µM. 
C) Sec18 is not required for the degradation of Vac17. Wild type or sec18-DAmP mutant cells 
were transformed with pRS416-Vac17-GFP. After FM4-64 labeling, cells were chased for 3 hr 
before imaging. DIC, differential interference contrast. Quantification of 40 large-budded cells 
per n, n=3. Error bars indicate SEM. Two-way ANOVA and Sidak’s multiple comparison. Scale 
bar = 5 µM. 
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Figure 3.11. Yck3 and Vps41 are required for the phosphorylation of Vac17. 
A) Schematic of Vac17 and Vac17-∆PEST. CC = predicted coiled coil. BD = binding domain. 
B) Purified recombinant GST-Yck3 (2-516) but not GST alone binds Vac17-TAP and Vac17-ΔPEST-
TAP from Vac17-TAP, Vac17-ΔPEST-TAP, and vps41Δ Vac17-ΔPEST-TAP lysates, respectively. 
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6.25% input (in). Molecular mass is shown in kilodaltons. Representative of n=3. NS = non-
specific band. Black arrowhead = Vac17-TAP. White arrowhead = Vac17-ΔPEST-TAP 
C) Purified recombinant HIS-MBP-ctVps41 (124-992) but not HIS alone binds Vac17-ΔPEST-TAP 
from Vac17-TAP, Vac17- ΔPEST-TAP, and yck3Δ Vac17- ΔPEST-TAP lysates. 6.25% input (in). 
Molecular mass is shown in kilodaltons. Representative of n=3. Black arrowhead = VAC17-TAP. 
White arrowhead = VAC17-ΔPEST-TAP  
D) Yck3 and Vps41 are required for the phosphorylation of Vac17-ΔPEST-GFP. Wild type, yck3∆, 
and vps41∆ mutant cells were transformed with pRS415-Vac17-∆PEST-GFP. λ-phosphatase 
treatment causes an increase in the electrophoretic mobility of Vac17-GFP in wild type, but not 
yck3∆ or vps41∆ mutant cells. Addition of phosphatase inhibitors restores the upper band in 
wild type cells. Representative of n=3. 
E) Yck3 and Vps41 -dependent phosphorylation of Vac17 requires binding to Myo2. 
vac17∆myo2∆, vac17∆myo2∆yck3∆, and vac17∆myo2∆vps41∆ mutant cells were co-
transformed with pRS416-Vac17-∆PEST-GFP and either pRS413-Myo2 or pRS413-myo2-
D1297N. The gel mobility of Vac17-∆PEST-GFP was analyzed via western blot. Pgk1 was used as 
a loading control. Molecular mass is shown in kilodaltons. Representative of n=3. 
F) Yck3 and Vps41 -dependent phosphorylation requires Vac8. Wild type, vac8∆, and 
vac8∆yck3∆vps41∆ mutant cells were transformed with pRS416-Vac17-∆PEST-GFP. The gel 
mobility of Vac17-∆PEST-GFP was analyzed via western blot. Pgk1 was used as a loading 
control. Molecular mass is shown in kilodaltons. Representative of n=3. 
G) Yck3-dependent phosphorylation of Vac17 does not require Dma1/Dma2. Wild type, 
dma1∆dma2∆, yck3∆, and dma1∆dma2∆yck3∆ mutant cells were transformed with pRS416-
Vac17-∆PEST-GFP and analyzed via western blot. Pgk1 was used as a loading control. Molecular 
mass is shown in kilodaltons. Representative of n=3. 
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Figure 3.12. Yck3 and Vps41 regulate the phosphorylation of Vac17 in its Myo2 binding 
domain 
 92 
A) Similar to deletion of Yck3, the vac17-4A mutant results in mislocalization of the vacuole 
(FM4-64) and accumulation of Vac17-GFP at the bud tip (open arrowheads) or mother-bud neck 
(closed arrows). vac17∆ or yck3∆vac17∆ mutant cells were transformed with pRS416-Vac17-
GFP or the Vac17 mutant indicated. After FM4-64 labeling, cells were chased at 24°C for 3 hr 
before imaging. DIC, differential interference contrast. Quantification of 40 large-budded cells 
per n, n=3. Error bars indicate SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 
µM. 
B) The non-phosphorylatable alanine mutant, vac17-4A, results in elevated levels of Vac17, 
similar to a yck3∆ mutant. vac17∆ or yck3∆vac17∆ mutant cells were transformed with pRS416-
Vac17-GFP or the Vac17 mutant indicated and analyzed via western blot. Pgk1 was used as a 
loading control. Molecular mass is shown in kilodaltons. Representative of n=3. 
C) Vac17-4A-GFP accumulates at the bud tip (open arrowheads) or mother-bud neck (closed 
arrows) in wild type and the pup1-K58E pup3-E151K mutant. This is in contrast to the pup1-
K58E pup3-E151K mutant alone, which results in Vac17 puncta (closed arrowheads). The vac17-
4E mutant had similar phenotypes to wild type Vac17. Wild type or pup1-K58E pup3-E151K 
mutant cells were transformed with pRS416-Vac17-GFP or the indicated Vac17 mutant. After 
FM4-64 labeling, cells were chased at 24°C for 3 hr before imaging. DIC, differential 
interference contrast. Quantification of 40 large-budded cells per n, n=3. Error bars indicate 
SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
D) The vac17-4A and pup1-K58E pup3-E151K mutants elevate Vac17 levels above wild type. 
Wild type or pup1-K58E pup3-E151K mutant cells were transformed with pRS416-Vac17-GFP or 
the indicated mutant and analyzed via western blot. Pgk1 was used as a loading control. 
Molecular mass is shown in kilodaltons. Representative of n=3.  
E) Mutation of the four phosphorylation sites in Vac17 at the Vac17-Myo2 interface does not 
alter binding to Myo2. Purified recombinant HIS-Vac17(1-355), either wild type, the -4A, or -4E 
mutants, but not HIS alone binds Myo2-TAP from yeast lysates. 6.25% input (in). Molecular 
mass is shown in kilodaltons. Representative of n=3.  
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Figure 3.13. Yck3 and Vps41 regulate the phosphorylation of Vac17 in its Myo2 and Vac8 
binding regions.  
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A) The phosphomimetic mutant, vac17-4E, does not have a defect in vacuole transport and 
does not suppress a yck3∆ mutant. vac17∆ or yck3∆vac17∆ mutant cells were transformed with 
pRS416-Vac17-GFP or pRS416-vac17-4E-GFP. After FM4-64 labeling, cells were chased at 24°C 
for 3 h before imaging. DIC, differential interference contrast. Quantification of 40 large-
budded cells per n, n=3. Error bars indicate SEM. Two-way ANOVA and Dunnett’s post-hoc test. 
Scale bar = 5 µM. 
B) The phosphomimetic mutant, vac17-4E, does not have a defect in Vac17 degradation and 
does not suppress a yck3∆ mutant. vac17∆ or yck3∆vac17∆ mutant cells were transformed with 
pRS416-Vac17-GFP or pRS416-vac17-4E-GFP and analyzed via western blot. Pgk1 was used as a 
loading control. Molecular mass is shown in kilodaltons. Representative of n=3. 
C) The phosphomimetic mutant, vac17-4E, does not have a defect in vacuole transport and 
does not suppress a vps41∆ mutant. vac17∆ or vps41∆vac17∆ mutant cells were transformed 
with pRS416-Vac17-GFP or pRS416-vac17-4E-GFP. After FM4-64 labeling, cells were chased at 
24°C for 3 h before imaging. DIC, differential interference contrast. Quantification of 40 large-
budded cells per n, n=3. Error bars indicate SEM. Two-way ANOVA and Dunnett’s post-hoc test. 
Scale bar = 5 µM. 
D) The phosphomimetic mutant, vac17-4E, does not have a defect in Vac17 degradation and 
does not suppress a vps41∆ mutant. vac17∆ or vps41∆vac17∆ mutant cells were transformed 
with pRS416-Vac17-GFP or pRS416-vac17-4E-GFP and analyzed via western blot. Pgk1 was used 
as a loading control. Molecular mass is shown in kilodaltons. Representative of n=3. 
E) Similar to wild type, the vac17-S269-272-275A mutant allowed for proper vacuole delivery. 
vac17∆ mutant cells were transformed with pRS416-Vac17-GFP or the corresponding mutant. 
After FM4-64 labeling, cells were chased at 24°C for 3 h before imaging. DIC, differential 
interference contrast. Quantification of 40 large-budded cells per n, n=3. Error bars indicate 
SEM. Two-way ANOVA and Dunnett’s post-hoc test. Scale bar = 5 µM. 
F) Compared to the yck3∆ mutant, the vac17-S269-272-275A mutant does not elevate Vac17 
levels, similar to wild type. vac17∆ or yck3∆ mutant cells were transformed with pRS416-Vac17-
GFP or the vac17-S269-272-275A mutant and analyzed via western blot. Pgk1 was used as a 
loading control. Molecular mass is shown in kilodaltons. Representative of n=3. 
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Figure 3.14. Ubiquitylation and Yck3 and Vps41 - dependent phosphorylation are required to 
release Vac17 from the vacuole. 
Previous studies found that Cla4 phosphorylates Vac17-S222. This phosphorylation event 
triggers the Dma1-dependent ubiquitylation of Vac17. In an independent and non-redundant 
parallel pathway, Yck3 and Vps41 are responsible for the phosphorylation of Vac17 in the Myo2 
binding domain. It is likely that additional unknown regulators are required in this pathway as 
well. The integration of these two signals lead to the dissociation of the Myo2-Vac17-Vac8 
complex and allow for Vac17 to be degraded by the proteasome after cargo release. 
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CHAPTER IV 
FUTURE DIRECTIONS 
 
 These studies have uncovered how Myo2 releases the vacuole at the right time and 
place. Previous studies revealed that the adaptor, Vac17, is ubiquitylated and degraded, and 
that the degradation of Vac17 is required for Myo2 to unload the vacuole. Our studies have 
identified a spatial cue that regulates this ubiquitylation step. Cla4, a p21-activated kinase, 
phosphorylates Vac17 when the vacuole reaches the bud cortex. This phosphorylation event is 
required for Dma1 to ubiquitylate Vac17 (Yau et al., 2017). It is also one of the few, if not only 
study, that identifies a spatial signal that triggers cargo release from a motor.  
My studies also revealed that a second pathway is required for the release of the 
vacuole from Myo2. This pathway occurs independently of ubiquitylation. Yck3 and Vps41 are 
required for the phosphorylation of Vac17 in its Myo2 binding region. This phosphorylation 
event dissociates ubiquitylated Vac17 from the Myo2-Vac17-Vac8 complex, and thus unloads 
the vacuole from Myo2. In many cases, ubiquitylation is the final step before degradation by 
the proteasome. This is one of the few cases where ubiquitylation is not sufficient for 
degradation. Such cases usually involve an AAA-ATPase to pry apart protein complexes, but we 
have not yet identified a AAA-ATPase required for the termination of vacuole transport.  
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It is likely that the mechanisms that regulate vacuole transport apply to other organelles 
in yeast, as well as to cargoes in mammalian cells. Thus, it is of high importance to advance our 
understanding of yeast vacuole transport.  
 
Dbf4 may regulate Dma1 to terminate vacuole transport  
Our published studies show that Cla4 directly phosphorylates Vac17 at Ser222 and that 
phosphorylation of this site is essential for the termination of vacuole transport (Yau et al., 
2017). Interestingly, phosphorylation of Vac17-S222 is not required for Dma1 recruitment 
because Dma1-3xGFP is recruited to the vacuole in the vac17-S222A mutant (Yau et al., 2014; 
Yau et al., 2017). However, phosphorylation of Vac17-S222 is required for Dma1 function, as 
the vac17-S222A mutant is not ubiquitylated and vacuole transport is not terminated (Yau et 
al., 2017). These data indicate that recruitment of Dma1 to the vacuole is necessary but not 
sufficient for the ubiquitylation and degradation of Vac17. It would be of great interest to 
determine how Cla4-dependent phosphorylation of Vac17 leads to the ubiquitylation of Vac17 
by Dma1. 
Cla4-dependent phosphorylation of Vac17-S222 may either (1) recruit a binding partner 
to facilitate Dma1 activity or (2) change the conformation of Vac17 to allow ubiquitylation. 
Based on our unpublished studies, the former is more likely. Vac17-F225, another residue in the 
PEST sequence, is also important for termination of vacuole transport and the vac17-F225S 
mutant shows a similar phenotype to vac17-S222A (Fig 4.1). Moreover, Vac17-S222 is still 
phosphorylated in the vac17-F225S mutant (data not shown). Together, these data suggest that 
pS222xxF225 recruits a binding partner that promotes Dma1 activity.  
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Notably, pSxxF is a known BRCT domain binding motif (Williams et al., 2004) and my 
preliminary data suggests that a BRCT domain protein, Dbf4 (Masai and Arai, 2000), plays a role 
in the termination of vacuole transport. Dbf4 is the activating subunit of Cdc7, which together 
form an essential kinase that has a known role in the initiation of DNA replication (Chapman 
and Johnston, 1989; Jackson et al., 1993). Notably, the dbf4-DAmP (Decreased Abundance by 
mRNA Perturbation (Breslow et al., 2008)) has a minor defect in the termination of vacuole 
transport (Fig 4.2). Note that DAmP alleles, used to test essential genes, lower the transcript 
level and are thus hypomorphs, which may not show robust phenotypes. Dbf4-Cdc7 is 
predominately found in the nucleus (Cheng et al., 1999; Lepke et al., 1999), thus it is surprising 
that it would have a role at the vacuole. However, it is possible that a small portion of Dbf4-
Cdc7 moves to the vacuole. There is precedence for the regulation of the vacuole by nuclear 
proteins. Cdk1, which is predominately in the nucleus, directly phosphorylates Vac17 (Peng and 
Weisman, 2008). Thus, it is possible that a subset of Dbf4 binds to Vac17 after Vac17-S222 is 
phosphorylated.  
While the Dbf4 may bind Vac17, the substrate may be a different member of the 
complex. Dbf4-Cdc7 is known to phosphorylate serines adjacent to acidic residues (Cho et al., 
2006). Interestingly, both Dma1 and the redundant E3 ligase, Dma2, have ES repeats in their C-
termini (Saccharomyces Genome Database). Dma1 has three potential phosphorylated serines, 
Dma1-S382, -S384, and –S386.  Mutation of all three serines to alanines (dma1-3SA) results in 
defects in the termination of vacuole transport: Vac17-GFP accumulates with dma1-3SA-
tdTomato at the bud tip and mother-bud neck and Vac17 levels are elevated in the dma1-3SA 
mutant (Fig 4.3). Moreover, levels of the dma1-3SA-GFP mutant are elevated compared to wild 
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type Dma1-GFP (Fig 4.3). Since Dma1 auto-ubiquitylates to regulate its levels (Loring et al., 
2008; Yau et al., 2014), this further indicates a defect in its enzymatic activity. I hypothesize that 
Vac17-pS222 recruits Dbf4-Cdc7, which phosphorylates Dma1 and results in activation of Dma1 
and the ubiquitylation of Vac17. An alternative hypothesis is that Dbf4-Cdc7 acts on Vac17 or 
other members of the complex, or other sites on Dma1, and it is possible that a different kinase 
regulates Dma1 at its C terminus. 
 
Determine if Dbf4 interacts with Vac17-pS222 
The first step would be to determine if and when Dbf4 interacts with Vac17. An in vivo 
assay, such as a BiFC (Hu et al., 2002) assay, could be utilized. Dbf4 would be tagged with the N 
terminus of Venus, while Vac17 would be tagged with the C terminus of Venus. If Dbf4 and 
Vac17 interact, fluorescence of the assembled Venus will be detected. BiFC between Vac8 and 
Vac17 could serve as a positive control for the assay. I expect that Dbf4 binds to Vac17 after 
Cla4 phosphorylates Vac17 at either the bud cortex or on the vacuole and that the vac17-S222A 
mutant ablates the interaction. As orthogonal approaches, in vitro binding and yeast two hybrid 
assays (Fields and Song, 1989) would corroborate if Vac17 directly binds to Dbf4. Vac8 (Tang et 
al., 2006) and Cdc7 (Ramer et al., 2013) will serves as positive controls known to directly 
interact with Vac17 and Dbf4, respectively. The vac17-S222A mutant and a Dbf4 mutant lacking 
the BRCT domain will serve as negative controls that will not interact with wild type Dbf4 and 
Vac17, respectively. These studies would reveal whether Dbf4 interacts with Vac17-pS222 in 
the bud. 
 
 100 
Determine if Dbf4-Cdc7 activity is required for ubiquitylation of Vac17 
If Vac17-pS222 recruits Dbf4, then it is possible that Dbf4-Cdc7 directly targets Dma1. I 
would test if Dbf4-Cdc7 directly phosphorylates Dma1 using an in vitro kinase assay (Jiang et al., 
1999; Tsuji et al., 2006). A kinase dead Dbf4-Cdc7 (Gerard et al., 2006) and the dma1-3SA 
mutant would serve as negative controls. I expect that wild type, but not kinase dead, Dbf4-
Cdc7 will phosphorylate Dma1, but not the dma1-3SA mutant, in vitro. A caveat is that previous 
studies used mammalian Dbf4-Cdc7 and it may be that an in vitro assay cannot be developed 
for the yeast proteins. As an orthogonal approach, I would determine if in vivo phosphorylation 
of Dma1 is ablated in loss-of-function Dbf7-Cdc7 temperature sensitive mutants (Jackson et al., 
1993). Phosphorylation status will be assessed by gel shifts in molecular weight on a low 
percentage SDS-PAGE gel. I predict less phosphorylation in the non-phosphorylatable dma1-3SA 
mutant protein and in wild type Dma1 in the Dbf4-Cdc7 mutants at the restrictive temperature. 
These studies will determine whether Dma1 is directly phosphorylated by Dbf4-Cdc7 at the 
ESESES motif. 
To determine if phosphorylation of Dma1 regulates the ubiquitylation of Vac17, I would 
perform in vivo ubiquitylation assays to determine if Vac17 is ubiquitylated by the dma1-3SA 
mutant. Wild type Dma1 would serve as a positive control for ubiquitylation of Vac17. vac17-
S222A, which cannot be ubiquitylated, would serve as a negative control. These data would test 
whether there is a functional relationship between phosphorylation of Dma1 and its ability to 
ubiquitylate Vac17. I would also test if other Dma1 targets, Swe1 (Raspelli et al., 2011) and Pcl1 
(Hernandez-Ortega et al., 2013), are stabilized in the dma1-3SA mutant via western blot and/or 
cannot be ubiquitylated by the dma1-3SA mutant via in vivo ubiquitylation assays. One caveat is 
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that the dma1-3SA mutant may be due to a general loss of function from an effect on the 
protein, as opposed to ablating its regulation.  
The dma1-3SD-GFP mutant does not have defects in vacuole transport, suggesting that 
it may function as a phosphomimetic allele (Fig 4.3). This genetic tool may be used to 
determine if Dbf4 is required for phosphorylation of Dma1, and if this event is required for 
Vac17 turnover. For example, the dma1-3SD mutant may suppress the Dbf4-DAmP allele if Dbf4 
is indeed regulating Dma1 at these sites.  
Future studies will determine whether phosphorylation of Dma1 facilitates its binding to 
an E2 ubiquitin-conjugating enzyme or activates Dma1 via another mechanism. These studies 
would reveal how Dma1 E3 ligase activity is spatially and temporally regulated.  
 
Yeast Two Hybrid Screen for Vac17-pS222xxF225 Binding Partners  
It is possible that Dbf4 is not the regulator recruited by Vac17-pS222xxF225. As an 
unbiased approach, I developed a yeast two hybrid screen to identify binding partners of 
Vac17-pS222xxF225. I found that the phosphomimetic vac17-S222E mutant did not have 
defects in vacuole transport and was still able to bind to Myo2 by yeast two hybrid (Fig 4.4). 
This suggests that vac17-S222E may function as a true phosphomimetic and interact with its 
binding partner. 
 
Preliminary screen suggests candidate may bind vac17-S222E but not vac17-S222A 
For the initial screen, a pGAD library (C3, a gift from Dr. Mara Duncan, University of 
Michigan) was transformed into cells containing a pGBD vector fused to the vac17-S222E (1-
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355) phosphomimetic mutant (Fig 4.5). The pGAD fragments of interacting clones were then 
isolated and sequenced. The isolated pGAD fragments were tested via a yeast two-hybrid assay 
for interaction with vac17-S222E and vac17-S222A mutants (Fig 4.5). This verified the 
interaction with vac17-S222E. Moreover, some candidates bound to vac17-S222E but not 
vac17-S222A and were pursued further as candidates that interact with Vac17-pS222. 
Sequencing analysis identified the gene at Upc2. However, deletion of Upc2 and/or its paralog 
Ecm22 did not result in elevated levels of Vac17 or defects in the termination of vacuole 
transport (Fig 4.6). Thus, it is likely that Upc2 was a false positive. Future studies should further 
analyze hits that interacted with both vac17-S222E and vac17-S222A, as it is possible that the 
screen was too stringent in identifying potential binding partners.  
Since this screen is not saturated, it is worth repeating with libraries containing different 
reading frames. The fact that some candidates bound vac17-S222E and not vac17-S222A 
suggest that this screen would be able to identify a true binding partner of Vac17-pS222. 
Mutation of the candidate should result in a defect in the termination of vacuole transport. 
Orthogonal verification may be conducted with vac17-F225S, which would be predicted to 
block binding to the candidate. This would provide support for the hypothesis that pS222xF225 
is indeed the binding motif.  
 
Determine if yeast two- hybrid screen candidates have a role in vacuole transport 
After identification of potential candidates, further verification and analysis would 
determine if these candidates are true regulators of vacuole transport. First, isolated 
candidates should be verified by yeast two-hybrid assays for interaction with vac17-S222E and 
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vac17-S222A. Potential binding partners would interact with vac17-S222E but not vac17-S222A. 
Next, loss of function mutants of candidates should be tested for defects in the termination of 
vacuole transport and should show phenotypes similar to vac17-S222A. In vitro binding assays 
and/or in vivo pulldown experiments would determine if the candidate is able to bind to Vac17 
but not vac17-S222A or vac17-F225S. If in vivo binding experiments cannot be performed, co-
localization experiments may provide evidence that the candidate interacts with Vac17 in the 
cell. If a candidate appears to have a role in vacuole transport, even without interacting with 
Vac17, it would be worthwhile to determine if the gene is required for the ubiquitylation of 
Vac17. If the candidate is not required for ubiquitylation, it may be involved in the Yck3 and 
Vps41 -dependent pathway and should be tested in this context.  
I predict that Vac17-pS222 recruits a kinase or kinase complex that phosphorylates, or 
otherwise activates, Dma1. This screen would reveal novel binding partners of Vac17-pS222 
that will be further tested for roles in terminating vacuole transport.  
 
Yck3 and Vps41 regulate peroxisome transport 
 Deletion of Dma1 results in the mis-localization of the vacuole to the mother-bud neck. 
Interestingly, peroxisomes also accumulate at the mother-bud neck in this mutant(Yau et al., 
2014). Thus, we tested if Yck3 and Vps41 also regulate peroxisome transport. Peroxisomes were 
labeled by integration of PTS1-GFP. Deletion of Yck3 and/or Vps41 results in accumulation of 
peroxisomes at the mother bud neck (Fig 4.7). This suggests that Yck3 and Vps41 regulate the 
transport of multiple cargoes, including the vacuole and peroxisomes, in yeast. 
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Peroxisomes were shown to be transport via their tethering to other organelles 
(Guimaraes et al., 2015; Salogiannis et al., 2016), which suggested that this phenotype may be 
due to indirect effects from defects in vacuole transport. However, this phenotype is not due to 
a defect in the termination of vacuole transport, as the vac17-∆PEST mutant is not defective in 
peroxisome transport (Fig 4.7). Thus, Yck3 and Vps41 may directly regulate peroxisome 
transport.  
 It would be interesting to determine how Yck3 and Vps41 regulate peroxisome 
transport. This mechanism could be through direct regulation of Inp2, the peroxisome adaptor. 
Although Yck3 and Vps41 have known roles on the vacuole, it is possible that a subset can 
localize to peroxisomes, either directly or through an organelle contact site. Similar to our 
studies on Vac17, it would be interesting to see if Inp2 is a direct target of Yck3 and Vps41. 
Alternatively, the defect in vacuole transport could be causing an indirect effect on peroxisome 
transport that is not apparent in the vac17-∆PEST mutant. The vac17-S127-S128-S131-T149A 
mutant that is not phosphorylated in a Yck3 and Vps41 -dependent manner should be tested 
for defects in peroxisome transport. These studies would provide greater mechanistic insight 
into how yeast organelles are detached from Myo2, as well as show that these mechanisms are 
used by multiple organelles. That some organelles are regulated by the same mechanisms 
would suggest that these events are coordinated in space and time.   
 
Vps41 and Yck3 may regulate the interaction between Myo2 and Vac17 
Our studies revealed that Yck3 and Vps41 regulate the phosphorylation of Vac17. SILAC 
experiments revealed that the phosphorylation of Vac17-∆PEST is altered in the vps41∆ and 
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yck3∆ mutants (Table 3, Table 4, respectively).Interestingly, Vps41 seems to be required for the 
phosphorylation of four Vac17 residues in its Myo2 binding region: S127, S128, S131, T149 (Fig 
3.12, 3.13). However, Yck3 has a moderate effect on only one of the four sites identified, S131 
(Table 4). Thus, it is likely that Vps41 recruits or regulates another kinase(s) that phosphorylates 
Vac17 in the Myo2 binding region. Alanine mutations in other potential phosphosites did not 
result in elevated Vac17 levels (Figure 3.12, 3.13, Table 5).  
Yck3 may phosphorylate Vac17 after it is primed by another kinase. Alternatively, Yck3 
may function as a priming kinase for another regulating kinase. For example, CK1 primes 
substrates for phosphorylation by GSK3 (Cesaro and Pinna, 2015; Xu et al., 2010). Interestingly, 
ILK and GSK3 regulate melanosome trafficking and transfer of melanin to keratinocytes 
(Crawford et al., 2020). Thus, Mck1 (Andoh et al., 2000), Ygk3 (Griffioen et al., 2003), Rim11 
(Bowdish et al., 1994), and Mrk1 (Byrne and Wolfe, 2005), the four yeast homologs of GSK3, are 
candidate kinases for Vac17. First, a loss of function GSK3 mutant should be tested for a defect 
in the termination of vacuole transport. If GSK3 appears to have a role in vacuole transport, 
further studies should determine if it is responsible for the phosphorylation of Vac17 in a 
Vps41-dependent manner. One caveat is that construction of this quadruple mutant may be 
difficult.  
Another possibility is that Yck3 may phosphorylate the Myo2 cargo binding domain. In 
one experiment, the phosphorylation of Myo2-S1131, -T1132, and -S1135 was slightly lowered 
in the yck3∆ mutant (Table 4). Note that our structure of Myo2 (1132-1572) includes residues 
beginning at 1152 (Pashkova et al., 2006), so it is unclear if Myo2-S1131, -T1132, and -S1135 are 
surface residues. If these residues reside on the surface, the non-phosphorylatable alanine 
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mutants should be tested for defects in the termination of vacuole transport. If no phenotype is 
observed, these mutations in Myo2 should be combined with the Vac17 phosphorylation 
mutants. Beyond testing these additional phosphorylation sites, it would be of great interest to 
determine how this event regulates the interaction between Vac17 and Myo2. This may be 
studied by in vitro binding assays, in vivo pulldowns, structural studies, or other methods. These 
studies would reveal if Yck3 has a role in regulating the interaction between Vac17 and Myo2.  
 
Vps41 and Yck3 may regulate the interaction between Vac17 and Vac8 
 Our studies suggest that Vps41 and Yck3 regulate the phosphorylation of Vac17 in the 
Myo2 binding region. This phosphorylation event may lead to the dissociation of Vac17 from 
the Myo2-Vac17-Vac8 complex. It is tempting to speculate that additional steps promote the 
dissociation of Vac17 from Vac8. SILAC experiments suggest that Vps41 and Yck3 regulate the 
phosphorylation of Vac17 in and near the Vac8 binding region: S269, S272, S275, S337, S338, 
S359 (Table 3, Table 4). However, mutation of these residues to the non-phosphorylatable 
alanine mutants did not have defects in the termination of vacuole transport (Fig 3.13, Table 5). 
Moreover, Yck3 and Vps41 may regulate the phosphorylation of Vac8-S16 (Table 3, Table 4). 
The vac8-S16A mutant alone or combined with vac17-S269-S272-S275-S337-S338-S359A does 
not have defects in vacuole transport (Fig 3.13).  
It is possible that currently unidentified events may be crucial to the dissociation of 
Vac17 and Vac8. SILAC experiments could be repeated with alpha factor arrest and release to 
test the phosphorylation of Vac17 during key points in the cell cycle, such as before (0min), 
during (50min), and after (100min) the vacuole is actively transported. Future investigation may 
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also want to include tests of full length Vac17, as the vac17-∆PEST mutant may be missing key 
regulatory residues and binding partners. This may be especially pertinent to regulation by 
Yck3, as the casein kinase I isoforms, Yck1 and Yck2, have been shown to regulate a PEST 
sequence in another protein (Marchal et al., 2000).  
 
Identification of the Vac17 ubiquitylation site  
The Vac17 ubiquitylation site is currently unknown. We had previously assumed that it 
was within the PEST sequence, since our studies focused on the PEST sequence’s role in Vac17 
degradation. With our new studies on Yck3 and Vps41, we have new genetic tools to study a 
stabilized Vac17 that is ubiquitylated and not degraded.  
Ubi4/ubiquitin(Ozkaynak et al., 1987) had increased interaction with Vac17 in vps41∆ 
(Table 6), but was not affected or perhaps even less interaction in yck3∆ (Table 7). This is 
opposite of our results from in vivo ubiquitylation assays, where ubiquitylation of Vac17 was 
increased in yck3∆ and about the same as wild type in vps41∆ (Fig 3.6). However, it is likely that 
Vac17 is more ubiquitylated in yck3∆ and/or vps41∆ since Vac17 is likely trapped in the 
complex in both mutants and has time to be hyper-ubiquitylated. It would be interested to test 
if increasing ubiquitylation of Vac17 can bypass yck3∆ and/or vps41∆ mutations. This can be 
done using inducible ubiquitylation of Vac17, such as auxin inducible degradation (AID) 
(Nishimura et al., 2009).  
SILAC suggested that Vac17 is ubiquitlated within the PEST sequence at K277 (Table 4). 
It would be of interest to verify that this is the site of ubiquitylation. Further studies may 
determine whether this is mono-ubiquitin or branched ubiquitin and if branched, what are the 
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linkages, as these different types of ubiquitylation may indicate different modes of regulation 
and signaling. 
 
Identification of Vac17 binding partners  
Our initial SILAC experiments with the Jason MacGurn lab (Vanderbilt University), were 
designed to identify phosphorylated residues in Vac17, but also revealed phosphopeptides that 
were presumably from other interacting proteins (Table 6, Table 7). Vac17-∆PEST appeared to 
interact less with Vac8, especially in yck3∆, and less with Myo2, especially in vps41∆. This aligns 
with our findings that Yck3 may regulate Vac17 dissociation with Vac8, and Vps41 may regulate 
Vac17 dissociation with Myo2. However, we would expect the deletion mutants to show 
increased binding with Vac8 or Myo2, while we observe the opposite. Further analysis may 
determine why this discrepancy occurs. One possibility is that it is an artifact of the experiment, 
which focused on detecting phosphorylated peptides.  
One experiment showed Vac17 had increased interaction with Atg18 in a yck3∆ mutant. 
Atg18 has roles in autophagy and the cytoplasm-to-vacuole targeting (CVT) pathway (Barth et 
al., 2001). It was previously shown that Atg18 and Vac17 interact in vivo and by yeast two-
hybrid, but the atg18∆ mutant did not have defects in vacuole transport (Efe et al., 2007). The 
functional significance of the interaction between Vac17 and Atg18 is currently unknown, but 
may indicate a role for Vac17 in vesicle trafficking that begins at the vacuole (Efe et al., 2007).    
Since our experiments focused on identifying phosphorylation sites, it would be worth 
performing experiments dedicated to identifying interactors of Vac17. These experiments 
should utilize full length Vac17. If full length Vac17 levels are not sufficient to perform these 
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experiments, we should consider point mutants that elevate Vac17 levels, but still allow most 
interactions. For example, the vac17-S222A mutant would allow interaction with Dma1 and 
other regulators, but not what binds to Vac17-pS222.   
It is likely that regulators related to the dissociation of the Myo2-Vac17-Vac8 complex 
will be identified. These regulators may work directly with the proteasome or somehow extract 
proteins from membrane complexes. If these experiments do not identify a new regulator, a 
more targeted screen should investigate AAA ATPases. One candidate is Msp1, a AAA ATPase 
on mitochondria that works with the proteasome (Nakai et al., 1993; Okreglak and Walter, 
2014). Identification of new Vac17 binding partners will reveal details about how Vac17 is 
regulated.  
 
Identification of novel genes required for vacuole transport 
It is likely that additional regulators are required for vacuole inheritance. This includes a 
binding partner that interacts with Vac17-pS222xxF225, as well as additional kinases that act in 
the Yck3 and Vps41-dependent pathway. Moreover, little is known about how the Myo2-Vac17-
Vac8 complex is formed aside from regulation by Cdk1, and phosphorylation by Cdk1 is likely 
not the only mode of regulation for the formation of the complex. 
To identify genes with roles in vacuole transport, we performed a Synthetic Genetic 
Array (SGA) screen (Cohen and Schuldiner, 2011). A query strain expressing endogenous Vac17-
Envy (a GFP variant (Slubowski et al., 2015)) was mated against the knockout (Guri Giaever, 
2002) and DAMP(Breslow et al., 2008) yeast collections. Automated microscopy collected 
images of the mutants, which were then analyzed by eye for mutants with elevated Vac17. 
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From the initial screen, we identified 181 candidate genes (Table 8). As expected, several genes 
involved with the proteasome were identified. Additionally, Dbf4 and Vps41, which were shown 
to have defects in the termination of vacuole transport, were also identified. Thus, our screen 
likely identified genes required for vacuole transport. However, the screen was not very 
sensitive, as it was hard to detect Vac17-Envy, and a different screen may be a more suitable 
future approach. 
To verify potential hits, we assessed candidates by microscopy. Candidates were 
transformed with a plasmid expressing Vac17-GFP and the vacuoles were stained with FM4-64. 
Top candidates were imaged and defects in either initiation or termination of vacuole transport 
were quantified compared to a dma1∆ control (Fig 4.9). Most candidates had defects in the 
initiation or termination of vacuole transport, while others had novel phenotypes that have not 
been previously reported. However, it is likely that these phenotypes were indirect effects or 
artifacts of the mutation and we suspect that many candidates are false positives.  
One interesting example, the pda1∆ mutant, showed puncta of Vac17 that were not on 
the vacuole or with Myo2 (Fig 4.9). These puncta are reminiscent of the puncta observed in loss 
of function proteasome mutants (Fig 3.7, Fig 3.8). Pda1 is a pyruvate dehydrogenase(Steensma 
et al., 1990) found near ERMES and peroxisomes(Cohen et al., 2014). While it is unclear how 
Pda1 may function in Vac17 degradation, it may hint at a link between vacuole transport and 
other organelles. It would be interested to determine if Pda1 functions in the ubiquitylation of 
Vac17, or acts in the Yck3 and Vps41 dependent pathway.  
Further studies may closely examine other candidates. It is possible that subtle 
phenotypes may become more apparent if related deletions, such as paralogs or partially 
 111 
redundant genes, are combined. Some genes currently have unknown functions and are not 
named, suggesting that novel players may have exclusive roles in vacuole transport. After 
verification of the phenotypes, it would be important to determine if these players directly 
regulate Vac17 or if the phenotypes are due to off target effects. Even if the candidates 
indirectly regulate vacuole transport, it may provide greater insight into how vacuole transport 
is coordinated with cellular processes.  
A more rigorous approach would be to redesign an unbiased screen for regulators of 
vacuole transport. This screen should focus on increasing sensitivity, such as by tagging Vac17 
with a brighter fluorophore. The screen should also be aware of new phenotypes that have only 
been described in recent years and may have be overlooked in past screening parameters. 
 
Open Questions without preliminary data 
Coordination between the initiation and termination of vacuole transport 
 There is likely interplay between the initiation and termination of vacuole transport. It is 
tempting to speculate that there are players that regulate both processes and/or signals that 
play into feedback loops. Some vacuole inheritance mutants are able to inherit vacuoles a 
minority of the time or are able to inherit small vacuoles. It would be interesting to determine if 
these inheritance mutants also have defects in the termination of vacuole transport. It is 
possible that some inheritance mutants will have defects in termination, while others do not. 
Further studies could determine why these differences exist.  
 
Coordination between function of the vacuole and vacuole transport 
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Just as there is likely coordination between the initiation and termination of vacuole 
transport, there may be coordination between vacuole transport and the functional status of 
the vacuole itself. It would be interesting to test if affecting different functions of the vacuole 
(fission, fusion, degradation, trafficking) by genetics, stress, or drugs, also affect vacuole 
transport. For example, loss of function CORVET mutants have defects in the initiation of 
vacuole transport (Banta et al., 1990). In some cells, the mother vacuole appears to be one 
large vacuole during budding, but then several smaller vacuoles after cell division (Fusheng 
Tang, 2003). This phenotype has not yet been properly tested, or quantified, but may indicate a 
correlation between vacuole fusion/fission dynamics and vacuole transport. Alternatively, it 
may indicate a correlation between endosome-vacuole fusion and other vacuole processes.   
 
Coordination of the termination of vacuole transport and the cell cycle 
The presence and maturity of the vacuole is required for budding (Jin and Weisman, 
2015). It is also possible that the termination of vacuole transport is coordinated with the cell 
cycle. Mutants that are defective in the termination of vacuole transport may have larger buds 
than wild type. This observation should be quantified. If significant, future studies may uncover 
how vacuole transport is coordinated with the cell cycle and bud size.  
One interesting possibility is that phosphatases may regulate Vac17 in coordination with 
the cell cycle. The phosphorylation of Vac17 is tightly regulated by space and time and 
facilitates interaction with its binding partners. Thus, it is possible that the dephosphorylation 
of certain Vac17 residues also have a role in the regulation of vacuole transport. Cdc14 may 
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have a role in vacuole transport, as the DAmP allele may have had a minor defect in the 
termination of vacuole transport (data not shown). 
 
Alternative pathways for Vac17 degradation 
Some termination mutants appear to accumulate Vac17-GFP in the vacuole. This 
phenotype should be quantified. This observation suggests that there is an alternative pathway 
for degradation when Vac17 cannot be ubiquitylated. This pathway may be a previously 
established degradation pathway, or a new pathway that has not been described. One 
possibility is the ESCRT pathway, which can transport vacuole membrane proteins into the 
vacuole for degradation (Li et al., 2015a; Li et al., 2015b; Oku et al., 2017).     
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A) 
 
B) 
 
Figure 4.1. Vac17-F225 is required for the termination of vacuole transport. A) vac17-F225S-
GFP mutant has a defect in the termination of vacuole transport similar to the vac17-S222A-
GFP mutant, where Vac17 and the vacuole are accumulated at the bud tip or mother-bud neck. 
n=3, 40 cells per n. p<0.05 students t test. B) vac17-F225S-GFP mutant results in accumulation 
of Vac17, similar to the vac17-S222A-GFP mutant. Representative of n=3.  
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Figure 4.2. Dbf4 may have a role in vacuole transport. The dbf4-DAMP mutant has a minor 
defect in the termination of vacuole transport. n=3, >13 cells per strain per experiment 
p-value = 0.06. students t test.  
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A) 
 
B)      C) 
    
 
D) 
 
Figure 4.3. Dma1 may be regulated by phosphorylation. A) The dma1-3SA-tdTomato mutant 
results in a defect in the termination of vacuole transport, where Vac17-GFP is accumulated 
and co-localized at the but tip and mother-bud neck. n=3, >17 cells per strain per experiment. 
Students t test. B) The dma1-3SA-GFP mutant results in elevated levels of endogenous Vac17. 
Representative n=3. C) The dma1-3SA-GFP mutant results in elevated levels of Dma1. 
Representative n=3. D) The dma1-3SD-GFP mutant does not have a defect in the termination of 
vacuole transport. n=3, >20 cells per strain per experiment. 
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A) 
 
 
B) 
 
Figure 4.4. Vac17-S222E may function as a phosphomimetic allele. A) Vac17-S222E-GFP does 
not have defects in the termination of vacuole transport. n=3, 40 cells per n. p<0.05, students t 
test. B) Vac17-S222E and Vac17-S222A are able to bind to Myo2. Since Dbf4 did not bind to the 
positive control, Cdc7, it is unclear if Dbf4 may bind to Vac17.  
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A) 
 
B) 
 
Figure 4.5. Yeast Two Hybrid screen reveals potential Vac17-pS222 interactors. A) The yeast 
two hybrid screen identified several clones that were able to interact with Vac17-S222E but not 
Vac17-S222A. Day 14. B) Verification of two clones, 6-5 and 13-2. Representative n=6, day 7 and 
day 11 as indicated.  
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Figure 4.6. Upc2 and paralog Ecm22 are not required for Vac17 degradation. Representative 
n=3.  
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A) 
 
B) 
 
Figure 4.7. Yck3 and Vps41 regulate peroxisome transport. A) Deletion of Yck3 and/or Vps41 
results in accumulation of peroxisomes at the bud tip and mother-bud neck. n=3, 40 cells per n. 
p<0.05, students t test. B) Peroxisome transport is not defective in the vac17-∆PEST mutant. 
n=3, 40 cells per n. p>0.3, students t test. 
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A) 
 
 
B) 
 
Figure 4.8. Yck3 and Vps41 may regulate phosphorylation of Vac17 and Vac17 binding 
partners.   
A) vac17∆ mutant cells were transformed with pRS416-Vac17-GFP (wild type or indicated 
mutant) and analyzed by western blot. Pgk1 served as a loading control.  
B) vac17∆vac8∆ mutant cells were co-transformed with pRS416-Vac17-GFP (wild type or 
S337A-S338A-S359A) and pRS415-Vac8-mCherry (wild type or S16A). Cultures were grown to 
log phase and imaged. Quantification of n=3, 40 cells per n. p>0.05, students t test.  
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A) 
 
B) 
 
 
Figure 4.9. Identification of potential regulators of vacuole transport. A) Analysis of verified 
candidates. n=1, 40 cells per n. B) Pda1 has an abnormal phenotype where Vac17-GFP 
accumulates in puncta that are not always on the vacuole or with Myo2. Representative images 
of 40 cells.  
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CHAPTER VI 
METHODS 
 
Yeast strains, plasmids, and media 
Yeast cultures were grown in yeast extract peptone dextrose (YEPD) containing 1% yeast 
extract, 2% peptone and 2% dextrose or synthetic complete (SC) media lacking the indicated 
amino acid(s) at 24°C unless specified. Yeast strains and plasmids listed in Tables 1 and 2, 
respectively. 
 
Western Blot analysis 
2-10 OD’s of cells were lysed in ice-cold 1 mL 0.2 M NaOH/ 0.2% β-mercaptoethanol and 
incubated on ice for 10 min. 100 μL trichloroacetic acid (TCA) was added to the lysates and 
incubated on ice for 5 min. Precipitated proteins were harvested via centrifugation at 13,000 
rpm for 5 min. Pellets were resuspended in 100 μL 2X SDS sample buffer (0.12M Tris-HCl (pH 
6.8), 19% Glycerol, 0.15 mM Bromophenol Blue, 3.8% SDS, 0.05% β-mercaptoethanol). 20 μL of 
1 M Tris base (pH 11) was then added and the samples were heated at 75°C for 10 min. Protein 
samples were loaded on 9% SDS PAGE gels made with Acrylamide/bis (30% 37.5:1; Bio-Rad) and 
run at 70-100V. Proteins were transferred onto nitrocellulose membrane at 35V for 19 hours. 
Membranes were blocked in milk before incubated in primary antibodies indicated. 
Membranes were washed 3x10min in TBST, incubated in secondary antibodies, washed again, 
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and developed with ECL or ECL prime. For immunoblot analyses, mouse anti-GFP (1:1,000; 
Roche), rabbit anti-TAP (1:1,000; Thermo Scientific), mouse anti-Pgk1 (1:10,000; Invitrogen), 
sheep anti-Vac17 (1:1,000; custom made, Twenty First Century Biochemicals), rabbit anti-
phosphoThr240 (1:2,500; custom made, 21st Century Biochemicals) and rabbit anti-
phosphoSer222 (1:2,500; custom made, 21st Century Biochemicals) antibodies were used (see 
Antibody Preparation). 
 
Immunoprecipitation experiments 
Cells were lysed and proteins were precipitated as described above. Precipitated 
proteins were washed with acetone, dried, and resuspended in 200 μL urea buffer (6 M urea, 
1% SDS, 50 mM Tris-HCl pH 7.5), and heated at 75°C for 10 min. 1.8 ml TWIP buffer (50 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 0.5% Tween-20, 0.1 mM EDTA) containing 1 mM Na3VO4 and 1X 
protease inhibitor cocktail (Sigma) was added to the resuspended protein and centrifuged. 4 μg 
of mouse anti-GFP antibodies (Roche) were added to the supernatant and incubated with 
agitation at 4°C, overnight. Immune complexes were harvested via the addition of protein G 
beads, which were subsequently collected via centrifugation and washed with TWIP buffer. 
Bound proteins were analyzed via immunoblot.  
 
In vivo ubiquitylation experiments 
To detect ubiquitylated Vac17, pVT102U-Vac17-GFP was transformed into vac17Δ, 
dma1Δdma2Δvac17Δ, yck3Δvac17Δ or vps41Δvac17Δ mutant strains. pVT102U-Vac17 was 
transformed into vac17Δ as a no-GFP control. A plasmid encoding Myc-Ub driven by a CUP1 
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promoter was co-transformed into the same strains. Myc-Ub expression was induced with 100 
μM CuCl2. GFP fusion proteins were immunoprecipitated as described above and analyzed via 
immunoblot using rabbit anti-GFP (Abcam), and rabbit anti-myc antibodies (1:2,000; Cell 
Signaling).  
 
Microscopy 
To visualize vacuoles, cells were labeled with either (1) 12 μg FM4-64 in 250 μL media 
for 1 hour, then washed twice and grown in 5 ml fresh media for one doubling time (2-3 hours), 
or (2) 100 uM CMAC (ThermoFisher) for 30 minutes, then washed twice in fresh media. Live cell 
images were obtained on a DeltaVision Restoration system (Applied Precision) using an 
inverted epifluorescence microscope (IX-71; Olympus) with a charge-coupled device camera 
(Cool-SNAP HQ; Photometrics) and processed in Photoshop and FIJI. 
 
Time Lapse Microscopy 
Glass-bottom chambers (Lab-Tek II; Thermo Fischer Scientific) were treated overnight at 
4°C with concanavalin A dissolved at 1 mg/ml in 50 mM HEPES, pH 7.5, 20 mM calcium acetate, 
and 1 mM manganese sulfate, then washed with water and air dried for 30 minutes. Cells 
adsorbed to concanavalin A-treated chambers for 2 minutes. Unbound cells were removed by 
aspiration and 250 l of fresh media was added. Time lapse microscopy was performed at 2 
minute intervals using a Nikon Ti-U inverted microscope with a 100x 1.4NA oil immersion 
objective, Lumencore light engine, Andor iXon DV897 camera, and GFP/mCherry dual-band 
filter set from Chroma. 
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Alpha Factor Cell Synchronization 
100 ml of cells (OD = 0.2-0.4) were incubated in 2.5 M alpha-factor (Zymo Research) for 
2-3 hours until 80% of cells were arrested in G1. Cells were washed in fresh media twice to 
remove alpha-factor. 1ml aliquots were collected every 10 minutes for live cell imaging, images 
taken within 5 minutes of collection. 
 
GST Protein Purification 
GST and GST-Yck3 were expressed in Rosetta (DE3) pLySS cells via induction with 0.1 mM IPTG 
at 30°C for 5 hours. Cells were resuspended in lysis buffer (50mM Tris pH 7.5, 150mM NaCl, 
5mM EDTA, 1 mM Pefabloc [Sigma-Aldrich], and cOmplete EDTA-free protease inhibitor cocktail 
[Roche]) and lysed via sonication. Lysates were clarified via centrifugation at 20,000 g for 30 
min at 4°C and incubated with glutathione beads at 4°C with agitation for 30min. The mixture 
was applied to a column and the beads were washed with wash buffer (50mM Tris pH 7.5, 
150mM NaCl, 5mM EDTA) until no protein was detected in the flow through. The beads were 
resuspended in elution buffer (50mM Tris pH 7.5, 150mM NaCl, 5mM EDTA, 10mM glutathione) 
and incubated at 4°C with agitation for 30min. The elution was collected and dialyzed overnight 
at 4°C in storage buffer (20 mM HEPES-NaOH pH 7.4, 250 mM NaCl, 10% Glycerol, 2 mM DTT). 
The protein was concentrated and stored at -80°C. 
 
GST Tag Binding Assay 
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GST and GST-Yck3 were expressed in Rosetta (DE3) pLySS cells (Novagen) via induction with 0.1 
mM IPTG at 30°C for 5 hours. Cells were resuspended in GST lysis buffer (50mM Tris pH 7.5, 
150mM NaCl, 5mM EDTA, 1 mM Pefabloc [Sigma-Aldrich], and cOmplete EDTA-free protease 
inhibitor cocktail [Roche]) and lysed via sonication. Lysates were clarified via centrifugation at 
20,000 g for 30 min at 4°C and incubated with glutathione beads at 4°C with agitation. 
Immobilized proteins were washed once with GST lysis buffer. Yeast cells grown in yeast extract 
peptone dextrose at 24°C were resuspended in yeast lysis buffer (125mM NaCl, 50mM NaPO4 
pH 7.4, 10% glycerol, 2mM MgCl2, 0.5% octylglucosidase, 1mM DTT, 1× protease inhibitor 
cocktail (Sigma-Aldrich), and cOmplete EDTA-free protease inhibitor cocktail (Roche)) and lysed 
with glass beads. GST- and GST-Yck3 bound beads were incubated with clarified yeast cell 
extracts for 1 hr at 4°C with agitation. Beads were then washed twice with yeast wash buffer 
(50mM HEPES-KOH pH 7.4, 150mM KCl, 1mM EDTA, 10% glycerol). Bound proteins were 
analyzed via SDS-PAGE, Gelcode blue staining, and immunoblotting. For input (6.25%), 20 μL 
lysate was resuspended in 20 μL sample buffer, and 5 μL was loaded into the gel. 
 
HIS Tag Binding Assay 
His and His-Vps41 were expressed in C43 (DE3) cells (Lucigen) vis induction with 0.5mM IPTG at 
30°C for 3 hours. Cells were resuspended in Vps41 lysis buffer (10mM HEPES pH 7.4, 350mM 
NaCl, 2mM MgCl2, 5% glycerol, 50mM imidazole, 100µM PMSF, 5mM β-mercaptoethanol) and 
lysed via sonication. Lysates were clarified via centrifugation at 20,000 g for 30 min at 4°C and 
incubated with Ni-NTA beads at 4°C with agitation for 1 hour. Immobilized proteins were 
washed twice with Vps41 lysis buffer. Yeast cells grown in yeast extract peptone dextrose at 
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24°C were resuspended in yeast lysis buffer (125mM NaCl, 50mM NaPO4 pH 7.4, 10% glycerol, 
2mM MgCl2, 0.5% octylglucosidase, 1mM DTT, 1× protease inhibitor cocktail (Sigma-Aldrich), 
and cOmplete EDTA-free protease inhibitor cocktail (Roche)) and lysed with glass beads. His- 
and His-Vps41 bound beads were incubated with clarified yeast cell extracts for 1 hr at 4°C with 
agitation. Beads were then washed twice with yeast wash buffer (50mM HEPES-KOH pH 7.4, 
150mM KCl, 1mM EDTA, 10% glycerol). Bound proteins were analyzed via SDS-PAGE, Gelcode 
blue staining, and immunoblotting. For input (6.25%), 20 μL lysate was resuspended in 20 μL 
sample buffer, and 5 μL was loaded into the gel. 
 
Lambda Phosphatase Treatment  
Log phase cells (20 OD600 units) were suspended in 1 mL ice cold 0.2M NaOH, 0.2% b-
mercaptoethanol (v/v), and incubated on ice for 10 min. 100μL trichloroacetic acid (TCA) was 
added and incubated on ice 10 min. Protein pellets were washed three times with acetone and 
air dried. The pellets were resuspended in 200 μL urea breaking buffer (6M Urea, 1% SDS, 
50mM Tris-HCl pH 7.5) and heated at 75°C. 1800 μL of TWIP (50mM Tris-HCl pH 7.5, 150mM 
NaCl, 0.5% Tween-20, 1× protease inhibitor cocktail (Sigma-Aldrich), NaVO4, 1mM PMSF ) was 
added and the lysate was spun 5000rpm 5min. 4μg/μL of mouse-anti-GFP was added to the 
supernatant and incubated 1 hr at 4°C with agitation. Protein G beads were added and 
incubated 1 hr at 4°C with agitation. Beads were washed in TWIP and resuspended in 50 μL 
master mix (40uL water + 5uL 1 × λ-phosphatase buffer + 1× protease inhibitor cocktail (Sigma-
Aldrich) + 5uL 10 mM MnCl2). Either water, λ-phosphatase (400 U; New England Biolabs, Inc.), 
or λ-phosphatase plus phosphatase inhibitors (100 mM NaF, 10 mM Na3VO4, 50 mM EDTA, 20 
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mM β-glycerophosphate, and 20 mM sodium pyrophosphate) were added to the reaction. 
Phosphatase reactions were incubated 1 hr at 30°C with agitation. Reactions were stopped with 
addition of 2x sample buffer (0.12M Tris-HCl (pH 6.8), 19% Glycerol, 0.15 mM Bromophenol 
Blue, 3.8% SDS, 0.05% β-mercaptoethanol).  The resultant samples were subjected to 
immunoblot analysis.  
 
SILAC 
LWY18795, LWY18802, and LWY18813 were co-transformed with pVT102u-Vac17-∆PEST-6xHis-
TEV-3xFLAG and pRS413-Myo2-D1297N. Note that the pRS413-Myo2-D1297N mutant was 
included to improve viability of the yeast, which may be negatively affected by over expression 
of Vac17 mutants that occupy Myo2 and prevent Myo2 from performing essential functions. 
SILAC-based mass spectrometry for quantitation and mapping of Vac17 phosphosites was 
performed as previously described (Albuquerque et al., 2008; Lee et al., 2019) with slight 
modification. Briefly, equal amount of light  wildtype) and heavy (Δyck3 or Δvps41, as indicated) 
cells expressing exogenous Vac17-ΔPEST-FLAG were harvested from mid-log phase and disrupted 
by bead beating using ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 
0.2% NP-40, 10 mM iodoacetamide, 1X EDTA-free protease inhibitor cocktail (Roche), 1mM 
phenylmethylsulfonyl fluoride, 20 µM MG132, 1X PhosStop (Roche), 10 mM NaF, 20 mM BGP, 
and 2 mM Na3VO4). Lysate was clarified by centrifugation at 21,000 x g for 10 min at 4ᵒC and 
supernatant was transferred into a new tube and diluted with threefold volume of ice-cold TBS 
(50 mM Tris-HCl, pH7.5, 150 mM NaCl). Vac17-ΔPEST-FLAG in 12-ml diluted lysate was enriched 
by incubation with 50 µL of EZview anti-FLAG M2 resin slurry (Sigma) for 2 hr at 4ᵒC with rotation. 
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The resin was washed three times with cold TBS and incubated with 90µl elution buffer (100 mM 
Tris-HCl, pH 8.0, 1% SDS) at 98ᵒC for 5 min. Collected eluate was reduced with 10mM DTT, 
alkylated with 20mM iodoacetamide, and precipitated with 300 µl PPT solution (50% acetone, 
49.9% ethanol, and 0.1% acetic acid). Light and heavy protein pellets were dissolved with Urea-
Tris solution (8 M urea, 50 mM Tris-HCl, pH 8.0). Heavy and light samples were combined, diluted 
fourfold with water, and digested with 1µg MS-grade trypsin (Gold, Promega) by overnight 
incubation at 37ᵒC. Phosphopeptides were enriched by immobilized metal affinity 
chromatography (IMAC) using Fe(III)-nitrilotriacetic acid resin as previously described (MacGurn 
et al., 2011), redissolved in 0.1% trifluoroacetic acid, and loaded onto a Q-Exactive mass 
spectrometer (Thermo Scientific). Resolved spectra were searched using MaxQuant (ver. 1.6.5.0) 
and chromatograms were visualized using Skyline (ver. 19.1.0.193, MacCoss Lab). 
 
Yeast Two Hybrid  
 Co-transform pGAD (LEU) and pGBD (URA) plasmids of interest into yeast and plate on 
SC-LEU-URA. When grown, patch single colonies onto SC-LEU-URA plates. After growth, replica 
plate using velvets onto SC-LEU-URA-HIS and SC-LEU-URA-HIS-ADE+3AT plates. Monitor growth 
at 24C.  
 
Plasmid Purification from Yeast 
15 ODs of yeast was pelleted at 3000rpm for 3 minutes. Pellet was resuspended in 250uL 
of P1 buffer with RNase (QIAGEN miniprep kit) and transferred to a fresh microcentrifuge tube. 
Cells were lysed at 4C via glass bead lysis for 10 minutes in bead beater. A hole was poked in the 
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bottom of the centrifuge tube and placed over a fresh centrifuge tube. Supernatant was 
recovered at 500g for 3 minutes. 250uL of P2 was added and the tube was inverted to mix. Within 
5 min, 350uL of N3 was added and the tube was inverted to mix. Sample was centrifuged at 
13000rpm for 10min. Supernatant was transferred to a DNA spin column and centrifuged at 
13000rpm for 1min. 750uL PE buffer was added and the sample was centrifuged at 13000rpm for 
1min. A dry spin at 13000rpm for 1min was performed to remove excess buffer. Plasmid DNA 
was eluted into a fresh tube with 40uL of elution buffer.  
 
Bacteria transformation 
 Frozen aliquots of competent bacteria cells were thawed on ice. 5-10uL of plasmid was 
added to 100uL of cells and incubated on ice for 30min. Cells were heat shocked at 42C for 1min 
and subsequently incubated on ice for 2 min. 250uL SOC media was added to the cells and tubes 
were incubated shaking at 37C for 30min. Cells were pelleted and plated on LB plates with 
appropriate antibiotics.  
 
 
 
 132 
TABLES 
 
Table 1. Yeast strains used in this study 
Strain Description  Citation 
LWY3250 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9 
This study 
LWY5798 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, vac17∆::TRP1 
Tang et al., Nature 2003 
LYW2887 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, vac8∆::HIS3 
Wang et al., JCB 1998 
LWY5826 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, vac17∆::TRP1, 
vac8∆::HIS3 
This study 
LWY11102 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, dma1∆::KAN 
Yau et al., Dev Cell 2014 
LWY11683 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, dma1∆::KAN 
dma2∆::KAN 
Yau et al., Dev Cell 2014 
LWY11687 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, dma1∆::KAN 
dma2∆::KAN vac17∆::TRP1 
Yau et al., Dev Cell 2014 
LWY11640 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, dma1∆::KAN 
dma2∆::KAN yck3∆::KAN 
Wong et al., Curr Biol 2020 
LWY14777 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, vps41∆::KAN 
Wong et al., Curr Biol 2020 
LWY14780 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, vps41∆::KAN, 
vac17∆::TRP1 
Wong et al., Curr Biol 2020 
LWY10924 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, vps39∆::KAN  
Wong et al., Curr Biol 2020 
LWY16184 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, yck3∆::KAN 
Wong et al., Curr Biol 2020 
LWY17494 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, yck3∆::KAN 
vac17∆::TRP1 
Wong et al., Curr Biol 2020 
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LWY18601 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, yck3∆::KAN 
vps41∆::KAN 
Wong et al., Curr Biol 2020 
LWY18556 MATa pep4∆::HIS3 prb1-∆1.6R lys2-208 trp1∆101 
vps41∆::KANMX  URA3::pRS406-NOP1pr-
VPS41wt 
Cabrera et al., Molec Biol 
Cell 2009 
LWY18558 LWY18558: MATa pep4∆::HIS3 prb1-∆1.6R lys2-
208 trp1∆101 vps41∆::KANMX  URA3::pRS406-
NOP1pr-VPS41 (S367, 368, 371, 372 A) 
Cabrera et al., Molec Biol 
Cell 2009 
LWY18560 LWY18560: MATa pep4∆::HIS3 prb1-∆1.6R lys2-
208 trp1∆101 vps41∆::KANMX  URA3::pRS406-
NOP1pr-VPS41 (S367, 368, 371, 372 D) 
Cabrera et al., Molec Biol 
Cell 2009 
LWY10332 MAT α, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, Vac17-TAP::LEU2 
Wong et al., Curr Biol 2020 
LWY18670 MAT α, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, Vac17-deltaPEST-
TAP::LEU2 
Wong et al., Curr Biol 2020 
LWY19035 MAT α, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, Vac17-deltaPEST-
TAP::LEU2, vps41-delta::KAN 
Wong et al., Curr Biol 2020 
LWY19196 MAT α, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, Vac17-deltaPEST-
TAP::LEU2, yck3-delta::KAN 
Wong et al., Curr Biol 2020 
LWT18737 MATα, GAL+ his3-Δ200 leu2-3,2-112 lys2-801 
suc2-Δ9 trp1-Δ9 ura3-52 
Banta et al., Molec Cell Bio 
1990 
LWT18738 MATα, vps33-4 GAL+ his3-Δ200 leu2-3,2-112 
lys2-801 suc2-Δ9 trp1-Δ9 ura3-52 
Banta et al., Molec Cell Bio 
1990 
LWY18763 MATα, vps11-delta::HIS3, pRS416-vps11-3, GAL+ 
his3-Δ200 leu2-3,2-112 lys2-801 suc2-Δ9 trp1-Δ9 
ura3-52 
Peterson and Emr, Traffic 
2001 
LWY18764 MATα, vps16-ts, GAL+ his3-Δ200 leu2-3,2-112 
lys2-801 suc2-Δ9 trp1-Δ9 ura3-52 
Peterson and Emr, Traffic 
2001 
LWY18765 MATα, vps18-ts, GAL+ his3-Δ200 leu2-3,2-112 
lys2-801 suc2-Δ9 trp1-Δ9 ura3-52 
Peterson and Emr, Traffic 
2001 
LWY7235 MATα, his3-11 leu2-3, 112 ura3-delta5 pre1-
1::can 
Chen and Hochstrasser, 
1996 Cell 
LWY7236 MATα, his3-delta200 leu2-3, 112 ura3-52 lys2-
801 trp1-1 doa3-
delta1::HIS3[YEpDOA3LS][YCPUbDOA3deltaLS] 
Arendt and Hochstrasser, 
1997 PNAS 
LWY7237 MATα, his3-delta200 leu2-3, 112 ura3-52 lys2-
801 trp1-1 doa3-
delta1::HIS3[YEpDOA3LS][YCPUbDOA3deltaLS-
T76A] 
Arendt and Hochstrasser, 
1997 PNAS 
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LWY7238 MATα, his3-delta200 leu2-3, 112 ura3-52 lys2-
801 trp1-1 pup1::leu2::HIS3 pup3-
delta2::HIS3[Ycplac22PUP1][Yeplac181PUP3] 
Arendt and Hochstrasser, 
1997 PNAS 
LWY7239 MATα, his3-delta200 leu2-3, 112 ura3-52 lys2-
801 trp1-1 pup1::leu2::HIS3 pup3-
delta2::HIS3[Ycplac22pup1-
K58E][Yeplac181pup3-E151K] 
Arendt and Hochstrasser, 
1997 PNAS 
LWY18807 MATα, his3-delta200 leu2-3, 112 ura3-52 lys2-
801 trp1-1 pup1::leu2::HIS3 pup3-
delta2::HIS3[Ycplac22PUP1][Yeplac181PUP3] 
yck3::KAN 
Wong et al., Curr Biol 2020 
LWY18808 MATα, his3-delta200 leu2-3, 112 ura3-52 lys2-
801 trp1-1 pup1::leu2::HIS3 pup3-
delta2::HIS3[Ycplac22pup1-
K58E][Yeplac181pup3-E151K]  yck3::KAN 
Wong et al., Curr Biol 2020 
LWY18810 MATα, his3-delta200 leu2-3, 112 ura3-52 lys2-
801 trp1-1 pup1::leu2::HIS3 pup3-
delta2::HIS3[Ycplac22PUP1][Yeplac181PUP3] 
vps41::KAN 
Wong et al., Curr Biol 2020 
LWY18811 MATα, his3-delta200 leu2-3, 112 ura3-52 lys2-
801 trp1-1 pup1::leu2::HIS3 pup3-
delta2::HIS3[Ycplac22pup1-
K58E][Yeplac181pup3-E151K] vps41::KAN 
Wong et al., Curr Biol 2020 
LWY12381 MATα, can1-100, leu2-3,-112, his3-11,-15,trp1-
1,ura3-1,ade2-1 cdc48-3 ts  
Verma et al., Molec Cell 
2011 
LWY12382 MATα, can1-100, leu2-3,-112, his3-11,-15,trp1-
1,ura3-1,ade2-1 
Verma et al., Molec Cell 
2011 
LWY6470 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0 This study 
LWY15465 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, vps4-
Δ::KAN 
Horizon Discovery 
LWY14289 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, dma1- 
Δ::KAN 
Horizon Discovery 
LWY18911 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, apl5- 
Δ::KAN 
Horizon Discovery 
LWY18912 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, aps3- 
Δ::KAN 
Horizon Discovery 
LWY18913 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, apl6- 
Δ::KAN 
Horizon Discovery 
LWY18665 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, vps3- 
Δ::KAN 
Horizon Discovery 
LWY18666 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, vps8- 
Δ::KAN 
Horizon Discovery 
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LWY19052 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, apm3- 
Δ::KAN 
Horizon Discovery 
LWY19425 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, sec18-
DAmP::KAN 
Breslow et al., Nature 
Methods 2008 
LWY19072 MATα, leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 
suc2-Δ9 lys2-801, arg4::KAN, pVT102u-Vac17-
deltaPEST-FLAG, pRS413-Myo2-D1297N 
Wong et al., Curr Biol 2020 
LWY19073 MATα, leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 
suc2-Δ9 lys2-801, arg4Δ::KAN, vps41Δ::KanMX, 
pVT102u-Vac17-deltaPEST-FLAG, pRS413-Myo2-
D1297N, vps41-KO 
Wong et al., Curr Biol 2020 
LWY19074 MATα, leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 
suc2-Δ9 lys2-801, arg4Δ::KAN, yck3Δ::KanMX, 
pVT102u-Vac17-deltaPEST-FLAG, pRS413-Myo2-
D1297N, yck3-KO 
Wong et al., Curr Biol 2020 
LWY7664 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, vac17Δ::TRP1, MYO2-
GFP::HIS3 
Peng et al. Dev Cell 2008 
LWY8195 MATa, ura3-52, leu2-3,-112, his3-∆200, trp1-
∆901, lys2-801, suc2-∆9, pep4-Δ1137, 
vac17∆::TRP1, myo2Δ::TRP1 [YCp50-MYO2] 
Yau and Wong et al. JCB 
2017 
LWY11109 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, dma1Δ::kanMX 
Yau and Wong et al. JCB 
2017 
LWY7422 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, cla4Δ::kanMX 
Yau and Wong et al. JCB 
2017 
LWY7429 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, ste20Δ::kanMX 
Yau and Wong et al. JCB 
2017 
LWY11860 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, ste20Δ::kanMX, 
cla4Δ::LEU2, Ycp-TRP1-cla4-75 
Yau and Wong et al. JCB 
2017 
LWY14298 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, cla4Δ::kanMX, 
vac17∆::TRP1 
Yau and Wong et al. JCB 
2017 
LWY14919 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, vac17∆::TRP1, Dma1-
3xGFP::HIS3 
Yau and Wong et al. JCB 
2017 
LWY14430 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, cla4Δ::kanMX, vac17-
3xGFP::TRP1 
Yau and Wong et al. JCB 
2017 
LWY11389 MATa, ura3-52, leu2-3,-112, his3-∆200, trp1-
∆901, lys2-801, suc2-∆9, dma1Δ::kanMX, 
dma2Δ::kanMX, VAC17-TAP::LEU2 
Yau and Wong et al. JCB 
2017 
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LWY15778 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, Cla4-3xGFP::HIS3, Vph1-
mCherry::KAN 
Yau and Wong et al. JCB 
2017 
LWY17427 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, lte1Δ::kanMX 
Yau and Wong et al. JCB 
2017 
LWY18484 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, Ste20-GFP::HIS3 
Yau and Wong et al. JCB 
2017 
LWY18493 MATa, ura3-52, leu2-3,-112, his3-Δ200, trp1-
∆901, lys2-801, suc2-∆9, Ste20-GFP::HIS3, 
cla4Δ::kanMX 
Yau and Wong et al. JCB 
2017 
LWY15569 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, dbf4-
DAMP::KANMX 
Horizon Discovery 
LWY18286 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, 
upc2Δ::KANMX 
Horizon Discovery 
LWY18396 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, Upc2-
GFP::HIS3MX6 
ThermoFisher Scientific 
LWY18747 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, promHIS3-GFPS65T-
PTS1::URA3 
This study 
LWY18748 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, promHIS3-GFPS65T-
PTS1::URA3, yck3Δ::KANMX 
This study 
LWY18749 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, promHIS3-GFPS65T-
PTS1::URA3, vps41Δ::KANMX 
This study 
LWY18750 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, promHIS3-GFPS65T-
PTS1::URA3, yck3Δ::KANMX, vps41Δ::KANMX 
This study 
LWY18819 MATα, ura3-52, leu2-3,-112, his3-Δ200, trp1-
Δ901, lys2-801, suc2-Δ9, promHIS3-GFPS65T-
PTS1::URA3, vac17Δ::TRP1 
This study 
LWY5055 PJ69: MATa, trp1-901 leu2-3,112 ura3-52 his 3-
200 gal4delta gal80delta GAL2-ADE2  
LYS2::GAL1-HIS3 met2::GAL7-lacZ 
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Table 2. Plasmids used in this study 
Plasmid Description Citation 
pRS415-Vac17-GFP AMP, LEU Tang et al., Nature 2003 
pRS416-Vac17-GFP AMP, URA Tang et al., Nature 2003 
pRS415-Vac17-∆PEST AMP, URA Tang et al., Nature 2003 
pRS416-Vac17-∆PEST AMP, URA Tang et al., Nature 2003 
pRS416-Vac17-∆PEST-GFP AMP, URA Tang et al., Nature 2003 
pRS416-Dma1-GFP AMP, URA Yau et al., Dev Cell 2014 
pRS413-Cla4-GFP AMP, HIS Yau and Wong et al., JCB 2017 
pRS413-Myo2-Venus AMP, HIS Yau and Wong et al., JCB 2017 
pRS416-Myo2-Venus AMP, URA Wong et al., Curr Biol 2020 
pRS413-Myo2-D1297N AMP, HIS Pashkova et al., EMBO J 2005 
pRS413-mCherry-Myo2 AMP, HIS Jin et al., Dev Cell 2011 
pRS406-VPS41pr-Vps41-WT AMP, URA Cabrera et al., MBOC 2009 
pRS406-VPS41pr-Vps41-4A AMP, URA Cabrera et al., MBOC 2009 
pRS406-VPS41pr-Vps41-4D AMP, URA Cabrera et al., MBOC 2009 
CUP1-Myc-Ubiquitin AMP, LEU Yau et al., Dev Cell 2014 
pvt102u-Vac17-GFP AMP, URA Yau et al., Dev Cell 2014 
pvt102u-Vac17 AMP, URA Yau et al., Dev Cell 2014 
pVT102u-Vac17-∆PEST-6xHis-TEV-
3xFLAG 
AMP, URA Wong et al., Curr Biol 2020 
pGEX-Yck3  (2-516) AMP Wong et al., Curr Biol 2020 
pSAP0162  (pQLinkHM-Vps41 (124-
992)  
AMP Wong et al., Curr Biol 2020 
pRS416-VAC17 CEN, URA3 Catlett et al., PNAS 1998 
pRS416-vac17-S222A-GFP CEN, URA3 Yau et al., Dev Cell 2014 
pRS416-vac17-T240A-GFP CEN, URA3 Yau et al., Dev Cell 2014 
pRS415-VAC17 CEN, LEU2 Yau et al., Dev Cell 2014 
pRS415-vac17-S222A CEN, LEU2 Yau et al., Dev Cell 2014 
pRS415-vac17-T240A CEN, LEU2 Yau et al., Dev Cell 2014 
pRS415-VAC17-GFP CEN, LEU2 Yau et al., Dev Cell 2014 
pRS415-vac17-S222A-GFP CEN, LEU2 Yau et al., Dev Cell 2014 
pRS415-vac17-T240A-GFP CEN, LEU2 Yau et al., Dev Cell 2014 
pRS413-CLA4 CEN, HIS3 Yau and Wong et al., JCB 2017 
pRS413-CLA4-tdTomato CEN, HIS3 Yau and Wong et al., JCB 2017 
pGEX4T- Cla4 Amp Versel et al., JCB 2004 
pGEX4T-cla4-K594A Amp Versel et al., JCB 2004 
pET-Vac17(97-260) Kan Yau and Wong et al., JCB 2017 
pRS415-Vac17-F225S-GFP Amp, LEU2 Richard Yau, unpublished 
pRS415-Vac17-S222E-GFP Amp, LEU2 Sara Wong, unpublished  
pGBD- Vac17-S222E (1-355) Amp, URA3 Sara Wong, unpublished 
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pGBD- Vac17-S222A (1-355) Amp, URA3 Sara Wong, unpublished 
pGBD- Vac17 (1-355) Amp, URA3 Ishikawa et al., JCB 2003 
pGAD-Upc2 Amp, LEU2 Nadia Azad, unpublished 
pRS416-Dma1-3SA-tdTomato Amp, URA3 Sara Wong, unpublished 
pRS416-Dma1-3SD-tdTomato Amp, URA3 Sara Wong, unpublished 
pRS416-Dma1-tdTomato Amp, URA3 Yau et al., Dev Cell 2014 
pRS416-Vac17-S269-S272-S275A-GFP Amp, URA3 Wong et al., Curr Biol 2020 
pRS416-Vac17-S127-S128-S131-
T149A-GFP 
Amp, URA3 Wong et al., Curr Biol 2020 
pRS416-Vac17-S127-S128-S131- GFP Amp, URA3 Wong et al., Curr Biol 2020 
pRS416-Vac17-T149A-GFP Amp, URA3 Wong et al., Curr Biol 2020 
pRS416-Vac17-S337-S338-S359A-GFP Amp, URA3 Sara Wong, unpublished 
pRS415-Vac8-mCherry Amp, LEU2 Sara Wong, unpublished 
pRS415-Vac8-S16A-mCherry Amp, LEU2 Sara Wong, unpublished 
pRS413-Vac8-mCherry Amp, HIS3 Noah Steinfeld, unpublished  
pEW161 (promHIS3-GFPS65T-
PTS1::URA3) 
Amp, URA3 Hoepfner et. al. 2001 
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Table 3. Quantitative analysis of Vac17 phosphorylation in vps41Δ mutant cells  
Vac17-FLAG was affinity purified from wildtype (light) and vps41Δ (heavy) cell lysates, and 
SILAC-MS was used to quantify relative abundance of phosphorylated peptides between the 
two samples. Individual H:L ratios in this table have been normalized to the average H:L ratio 
for unmodified Vac17 peptides in each respective experiment. 
 
Position 
H:L ratio 
(experiment 1) 
H:L ratio 
(experiment 2) 
Vac17-S34 0.68912  
Vac17-S35 0.68912  
Vac17-S68 0.738111  
Vac17-S127 0.575253 0.520017 
Vac17-S128 0.592645 0.616237 
Vac17-S131 0.388322 0.558716 
Vac17-T149 0.472177 0.281926 
Vac17-S170 0.675639  
Vac17-T172 0.724191 0.360831 
Vac17-S174 0.690914 0.414631 
Vac17-S178 0.679003 0.541881 
Vac17-S194  0.791404 
Vac17-S269 0.832837 0.589798 
Vac17-S272 0.200448 0.180742 
Vac17-S275 0.141797 0.133062 
Vac17-S337  0.39957 
Vac17-S359 0.396888 0.681269 
Vac8-S16 0.128755874  
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Table 4. Quantitative analysis of Vac17 phosphorylation in yck3Δ mutant cells 
Vac17-FLAG was affinity purified from wildtype (light) and yck3Δ (heavy) cell lysates, and SILAC-
MS was used to quantify relative abundance of phosphorylated peptides between the two 
samples. One experiment detected a change in the ubiquitylation of Vac17-K277. Individual H:L 
ratios in this table have been normalized to the average H:L ratio for unmodified Vac17 
peptides in each respective experiment. 
 
Position H:L ratio (experiment 1) 
H:L ratio 
(experiment 2) 
Vac17-S44 1.47432  
Vac17-S127 1.280887 0.825995 
Vac17-S128 1.053939 0.997896 
Vac17-S131 0.824886 0.59168 
Vac17-T149 1.105163 1.420743 
Vac17-S170 0.902029  
Vac17-T172 0.931135  
Vac17-S174 0.748762 1.606786 
Vac17-S178 0.962073 1.83307 
Vac17-Y267  0.378862 
Vac17-S269 0.902164 0.872216 
Vac17-S272 0.898501 0.68222 
Vac17-S275 0.459455 0.452034 
Vac17-S337  0.989742 
Vac17-S338  1.014203 
Vac17-S359 1.332655 1.092934 
Vac17-K277 (Ub)   0.9239 
Vac8-S16  0.37341 
Myo2-S1131  0.644607 
Myo2-T1132  0.884532 
Myo2-S1135  0.755098 
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Table 5. Alanine mutants tested for defects in the termination. 
pRS416-Vac17-GFP or pRS415-Vac8-mCherry was mutated by site directed mutagenesis PCR, 
and then transformed into LWY5798 or LWY5826. Mutants were assayed by western blot 
and/or microscopy. Mutants with a defect in vacuole transport are bold.  
 Vac17   
 127, 128, 131 
 149  
 127, 128, 131, 149 
 170, 172, 174 
 149, 170, 172, 174 
 127, 128, 131, 149, 170, 172, 174 
 269, 272, 275 
 
269, 272, 275, 127, 128, 131, 149, 170, 172, 
174 
 337, 338, 359 
 269, 272, 275, 337, 338, 359 
Vac8 16  
 11, 16  
Vac17 + 
Vac8 Vac17 Vac8 
 269, 272, 275 16 
 269, 272, 275, 337, 338, 359 16 
 267, 269, 272, 275 11, 16 
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Table 6. Quantitative analysis of Vac17 interactions in vps41Δ mutant cells  
Vac17-FLAG was affinity purified from wildtype (light) and vps41Δ (heavy) cell lysates, and 
SILAC-MS was used to quantify relative abundance of interacting peptides between the two 
samples. Note that experiment 1 interaction analysis was performed on the IMAC sample and 
experiment 2 was performed on the input sample. 
 
 Experiment 1 Experiment 2 
Summary raw H:L normalized (to Vac17) H:L raw H:L normalized (to Vac17) H:L 
Vac17 1.1149 1 0.64591 1 
Vac8 0.92788 0.832254 0.71194 1.102228 
Myo2 0.71222 0.63882 0.17463 0.270363 
Ubi4 3.7754 3.386313 1.1775 1.823009 
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Table 7. Quantitative analysis of Vac17 interactions in yck3Δ mutant cells  
Vac17-FLAG was affinity purified from wildtype (light) and yck3Δ (heavy) cell lysates, and SILAC-
MS was used to quantify relative abundance of interacting peptides between the two samples. 
Note that experiment 1 interaction analysis was performed on the IMAC sample and 
experiment 2 was performed on the input sample. 
 
 Experiment 1 Experiment 2 
Summary raw H:L normalized (to Vac17) H:L raw H:L normalized (to Vac17) H:L 
Vac17 1.4739 1 1.0973 1 
Vac8 0.74668 0.506602 0.91816 0.836745 
Myo2 1.232 0.835878 0.94442 0.860676 
Ubi4 1.2287 0.833639 1.0657 0.971202 
Atg18   1.3847 1.261916 
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Table 8. Potential regulators of vacuole transport. Results from the SGA screen. 
Systematic Name Standard Name Function/Localization 
YLL040C vps13 cell organization 
YAL067C seo1 organelle membrane 
YLR121C yps3 organelle membrane 
YMR141C unknown unknown 
YML086C alo1 enzyme 
YMR144W fdo1 nucleus 
YAL053W flc2 organelle membrane 
YAL045C unknown unknown 
YAL040C cln3 cell cycle 
YLR011W lot6 enzyme 
YML084W unknown unknown 
YMR145C nde1 mitochondria 
YAL021C ccr4 nucleus 
YML057W cmp2 enzyme 
YML056C imd4 enzyme 
YMR166C mme1 mitochondria 
YMR169C ald3 enzyme 
YMR174C pai3 enzyme 
YLR047C fre3 enzyme 
YAL005C ssa1 nucleus 
YLR059C rex2 mitochondria 
YAR028W unknown unknown 
YMR195W icy1 unknown 
YML008C erg6 ergosterol synthesis 
YAR030C unknown unknown 
YAR035W yat1 mitochondria 
YAR037W unknown unknown 
YAR040C unknown unknown 
YLL001W dnm1 mitochondria 
YML006C gis4 unknown 
YMR219W esc1 nucleus 
YMR221C fmp42 unknown 
YMR232W fus2 cell organization 
YMR031C eis1 cell trafficking 
YNL270C alp1 organelle membrane 
YNL266W unknown unknown 
YNL264C pdr17 lipid regulation 
YOL024W unknown unknown 
YOL028C yap7 nucleus 
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YOR295W uag30 nucleus 
YOL042W ngl1 nucleus 
YOR007C sgt2 stress response 
YOR008C slg1 stress response 
YOR320C gnt1 enzyme 
YOR036W pep12 cell trafficking 
YOR052C tmc1 stress response 
YOR376W unknown unknown 
YPL259C apm1 cell trafficking 
YPL232W sso1 cell trafficking 
YDR080W vps41 cell trafficking 
YPL194W ddc1 nucleus 
YDR090C unknown unknown 
YDR097C msh6 nucleus 
YDR415C unknown unknown 
YPL157W tgs1 nucleus 
YPL144W poc4 proteasome 
YPL136W unknown unknown 
YDR144C mkc7 enzyme 
YPL111W car1 enzyme 
YPL105C syh1 unknown 
YGR153W unknown unknown 
YHR200W rpn10 proteasome 
YGR181W tim13 mitochondria 
YCL008C stp22 cell trafficking 
YHR075C ppe1 enzyme 
YHR077C nmd2 nucleus 
YER048C caj1 nucleus 
YGR202C pct1 lipid regulation 
YCL026C unknown unknown 
YCL040W glk1 enzyme 
YCL044C mgr1 mitochondria 
YHL044W unknown unknown 
YCR004C ycp4 unknown 
YLR170C aps1 cell trafficking 
YKL075C unknown unknown 
YKL106W aat1 mitochondria 
YKL109W hap4 nucleus 
YOR211C mgm1 mitochondria 
YGR107W unknown unknown 
YKL142W mrp8 unknown 
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YOR106W vam3 cell trafficking 
YOR252W tma16 unknown 
YKL048C elm1 cell cycle 
YKL055C oar1 mitochondria 
YKL062W msn4 nucleus 
YOR135C irc4 unknown 
YJL204C rcy1 cell trafficking 
YGL237C hap2 nucleus 
YLR239C lip2 mitochondria 
YJL148W rpa34 nucleus 
YLR257W unknown unknown 
YPL089C rlm1 nucleus 
YPL055C lge1 unknown 
YBL007C sla1 cell organization 
YPL048W cam1 nucleus 
YBL021C hap3 nucleus 
YDR363W-A sem1 proteasome 
YPL002C snf8 cell trafficking 
YPR122W axl1 cell organization 
YNL205C unknown unknown 
YNL179C unknown unknown 
YIL070C mam33 mitochondria 
YMR063W rim9 unknown 
YFR021W atg18 cell trafficking 
YGR263C say1 organelle membrane 
YMR316C-A unknown unknown 
YOL109W zeo1 cell organization 
YJR035W rad26 nucleus 
YLR438W car2 stress response 
YLR449W fpr2 nucleus 
YDR043C nrg1 nucleus 
YJR060W cbf1 nucleus 
YJR061W mnn14 unknown 
YBR296C pho89 enzyme 
YAL058C-A unknown unknown 
YCL074W unknown unknown 
YCR077C pat1 nucleus 
YGL219C mdm34 organelle membrane 
YIL132C csm2 nucleus 
YIL153W rrd1 cell cycle 
YNR001C cit1 mitochondria 
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YIR001C sgn1 nucleus 
YMR048W csm3 nucleus 
YMR160W unknown unknown 
YDR497C itr1 lipid regulation 
YBR082C ubc4 ubiquitin 
YNL142W mep2 enzyme 
YER178W pda1 enzyme 
YML073C rpl6a ribosome 
YPL050C mnn9 enzyme 
YDR512C emi1 unknown 
YML111W bul2 ubiquitin 
YAL037C-A unknown unknown 
YBL008W-A unknown unknown 
YBL101W-C unknown unknown 
YBR196C-B unknown unknown 
YBR221W-A unknown unknown 
YCL057C-A mic10 mitochondria 
YBR072C-A unknown unknown 
YBR221W-A unknown unknown 
YGL006W-A unknown unknown 
YMR013W-A unknown unknown 
YGR146C-A unknown unknown 
YOL077W-A atp19 mitochondria 
YJL136W-A unknown unknown 
YBR109C cmd1 cell organization 
YBR121C grs1 mitochondria 
YBR143C sup45 nucleus 
YDR052C dbf4 nucleus 
YFL038C ypt1 cell trafficking 
YGR083C gcd2 nucleus 
YGR280C Pxr1 nucleus 
YCR057C pwp2 ribosome 
YIR012W sqt1 ribosome 
YDR238C sec26 cell trafficking 
YDL015C tsc13 organelle membrane 
YBL004W upt20 ribosome 
YDL097C rpn6 proteasome 
YDR331W gpi8 enzyme 
YDR362C tfc6 nucleus 
YIL171W unknown unknown 
YKL144C rpc25 nucleus 
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YER012W pre1 proteasome 
YGR186W tfg1 nucleus 
YHR042W ncp1 ergosterol synthesis 
YGL011C scl1 proteasome 
YGL022W stt3 enzyme 
YJR057W cdc8 nucleus 
YLR141W rrn5 nucleus 
YLR166C sec10 cell trafficking 
YMR314W pre5 proteasome 
YNL038W gpi15 enzyme 
YPR103W pre2 proteasome 
YOR261C rpn8 proteasome 
YOL038W pre6 proteasome 
YPL128C tbf1 nucleus 
YMR220W erg8 ergosterol synthesis 
YOR060C unknown unknown 
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